Processing 00000000.tx.1: Journal of Histochemistry and Cytochemistry, Vol. 

Phrase: "Journal of Histochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Cytochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010741:Cytochemistry [Biomedical Occupation or Discipline]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.2: 50, 789-798, June 2002, Copyright  2002, The Histochemical Society, Inc. 

Phrase: "50,"

Phrase: "789-798,"

Phrase: "June 2002,"

Phrase: "Copyright  2002,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009993:Copyright [Intellectual Product]
   861   C1552856:copyright [Idea or Concept]

Phrase: "The Histochemical Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "Inc."
Processing 00000000.tx.3: ARTICLE Expression of the Novel Epithelial Ca2+ Channel ECaC1 in Rat Pancreatic Islets Susan W.J. 

Phrase: "ARTICLE Expression of the Novel Epithelial Ca2+ Channel ECaC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Rat Pancreatic Islets Susan W.J."
Processing 00000000.tx.4: Janssena,b, Joost G.J. 

Phrase: "Janssena,"

Phrase: "b,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Joost G.J."
Processing 00000000.tx.5: Hoenderopc, Ad R.M.M. 

Phrase: "Hoenderopc,"

Phrase: "Ad"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.6: Hermusb, Fred C.G.J. 

Phrase: "Hermusb,"

Phrase: "Fred C.G.J."
Processing 00000000.tx.7: Sweepd, Gerard J.M. 

Phrase: "Sweepd,"

Phrase: "Gerard J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.8: Martensa, and Ren J.M. 

Phrase: "Martensa,"

Phrase: "and"

Phrase: "Ren J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.9: Bindelsc a Department of Animal Physiology, Faculty of Science, University of Nijmegen, Nijmegen, The Netherlands, University Medical Centre Nijmegen, Nijmegen, The Netherlands b Departments of Endocrinology, University Medical Centre Nijmegen, Nijmegen, The Netherlands c Cell Physiology, University Medical Centre Nijmegen, Nijmegen, The Netherlands d Chemical Endocrinology, University Medical Centre Nijmegen, Nijmegen, The Netherlands Correspondence to: Ren J.M. 

Phrase: "Bindelsc"

Phrase: "a Department of Animal Physiology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Faculty of Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0015535:Faculty [Professional or Occupational Group]

Phrase: "University of Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Nijmegen,"

Phrase: "The Netherlands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "University Medical Centre Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Nijmegen,"

Phrase: "The Netherlands b Departments of Endocrinology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0587463:Endocrinology department [Health Care Related Organization]
   719   C1704729:Department [Organization]

Phrase: "University Medical Centre Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Nijmegen,"

Phrase: "The Netherlands c Cell Physiology,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0007613:Cell physiology [Cell Function]
   840   C1325880:cell physiology [Cell Function]
   804   C0031842:Physiology [Biomedical Occupation or Discipline]
   804   C0031843:physiology [Physiologic Function]
   733 E C0205463:Physiologic [Functional Concept]

Phrase: "University Medical Centre Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Nijmegen,"

Phrase: "The Netherlands d Chemical Endocrinology,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   733 E C0694557:endocrinologic [Functional Concept]

Phrase: "University Medical Centre Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Nijmegen,"

Phrase: "The Netherlands Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Ren J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.10: Bindels, 160 Cell Physiology, University Medical Centre Nijmegen, PO Box 9101, NL-6500 HB Nijmegen, The Netherlands. 

Phrase: "Bindels,"

Phrase: "160 Cell Physiology,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0007613:Cell physiology [Cell Function]
   901   C1325880:cell physiology [Cell Function]
   827   C0031842:Physiology [Biomedical Occupation or Discipline]
   827   C0031843:physiology [Physiologic Function]
   755 E C0205463:Physiologic [Functional Concept]

Phrase: "University Medical Centre Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "PO Box 9101,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0179400:Box [Manufactured Object]
   827   C0442027:PO [Spatial Concept]
   827   C1533124:Box [Medical Device]

Phrase: "NL-6500 HB Nijmegen,"

Phrase: "The Netherlands."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands
Processing 00000000.tx.11: E-mail: reneb@sci.kun.nl Summary Top Summary Introduction Materials and Methods Results Discussion Literature Cited The epithelial Ca2+ channel, ECaC1, is primarily expressed in the apical membrane of vitamin D-responsive tissues. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "reneb@sci.kun.nl Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "The epithelial Ca2+ channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "ECaC1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "primarily"

Phrase: "expressed in the apical membrane of vitamin D-responsive tissues."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   760   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0596119:apical membrane [Cell Component]
   760   C2936842:Vitamin D [Pharmacologic Substance]
   760   C3537249:vitamin D [Pharmacologic Substance]
   757   C0025255:Tissues, Membrane [Tissue]
           Membrane
   739   C0040300:Tissues [Tissue]
   739   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   739   C0205111:Apical [Spatial Concept]
   739   C0205342:Responsive [Functional Concept]
   739   C0596901:Membrane [Cell Component]
   739   C1706182:Membrane [Manufactured Object]
   706 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.12: This study characterizes for the first time the presence of this novel channel in pancreatic tissue by reverse transcriptase-polymerase chain reaction and immunohistochemistry. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "characterizes for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "the presence of this novel channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in pancreatic tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "by reverse transcriptase-polymerase chain reaction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "immunohistochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.13: In addition, the expression of ECaC1 was investigated in an animal model for Type 2 diabetes mellitus, the Zucker diabetic fatty (ZDF) rat. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the expression of ECaC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "investigated in an animal model"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0599779:Animal Model [Animal]
   760   C0003062:Animal [Animal]
   760   C1292732:investigated [Functional Concept]
   760   C3161035:Model [Intellectual Product]

Phrase: "for Type 2 diabetes mellitus,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "the Zucker diabetic fatty (ZDF) rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Zucker rat [Mammal]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
Processing 00000000.tx.14: Identical staining patterns for ECaC1 and insulin were observed, whereas no co-localization of ECaC1 with glucagon was found. 

Phrase: "Identical staining patterns for ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0449778:patterns staining [Spatial Concept]
   748   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "whereas"

Phrase: "no co-localization of ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "with glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "found."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]
Processing 00000000.tx.15: ECaC1, insulin, and prohormone convertase 1 (a neuroendocrine endoprotease expressed in secretory granules) showed a similar punctate staining. 

Phrase: "ECaC1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "prohormone convertase 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
   901   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: "("

Phrase: "a neuroendocrine endoprotease"

Phrase: "expressed in secretory granules"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0886515:Secretory Granules [Cell Component]
   799 E C3271154:Secretory Granule [Cell Component]
   770   C0010837:Granules [Cell Component]
   770   C0993609:Granules [Biomedical or Dental Material]
   770   C1327616:Secretory [Cell Function]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a similar punctate staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
Processing 00000000.tx.16: ECaC1 co-localized with the Ca2+ binding protein calbindin-D28K in the -cells. 

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "co-localized with the Ca2+ binding protein calbindin-D28K"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   790   C0251337:Ca2+-binding protein- [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   764   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762 E C0033618:Protein Binding [Molecular Function]
   762   C2610644:CO binding [Molecular Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0054444:Calbindin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0243122:binding [Functional Concept]
   742   C0392752:Localized [Spatial Concept]
   742   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "in the -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.17: Furthermore, in contrast to wild-type rats, in ZDF rats aging led to a progressive decrease in both insulin and ECaC1 staining. 

Phrase: "Furthermore,"

Phrase: "in contrast to wild-type rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   896   C0034693:Wild rat [Mammal]
           rats
   827   C0034721:Rats [Mammal]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "in ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "led to a progressive decrease"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0205329:Progressive [Functional Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1708698:LED [Manufactured Object]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "ECaC1 staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]
Processing 00000000.tx.18: Plasma 1,25-dihydroxyvitamin D3 levels were similar in both control and ZDF rats and decreased with aging. 

Phrase: "Plasma 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "25-dihydroxyvitamin D3 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "similar in both control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "decreased with aging."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0001811:Ageing [Organism Function]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.19: Taken together, our findings indicate that this novel Ca2+ channel may play a role in the regulation of endocrine Ca2+ homeostasis. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "this novel Ca2+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the regulation of endocrine Ca2+ homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.20: (J Histochem Cytochem 50:789798, 2002) Key Words: -cell, calbindin-D28K, 1,25-dihydroxyvitamin D3, NIDDM, ZDF rat Introduction Top Summary Introduction Materials and Methods Results Discussion Literature Cited THE epithelial Ca2+ channel ECaC1 was recently cloned from rabbit kidney and was thought to play a crucial role in Ca2+ homeostasis as gatekeeper of active transcellular Ca2+ transport (Hoenderop et al. 1999a , Hoenderop et al. 2000b ). 

Phrase: "(J Histochem Cytochem 50"

Phrase: ":"

Phrase: "789798,"

Phrase: "2002"

Phrase: ")"

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ": -"

Phrase: "cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "calbindin-D28K,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "25-dihydroxyvitamin D3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]

Phrase: "NIDDM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011860:NIDDM [Disease or Syndrome]
  1000   C3273872:NIDDM [Gene or Genome]

Phrase: "ZDF rat Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "THE epithelial Ca2+ channel ECaC1"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "cloned from rabbit kidney"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0009013:cloned [Cell]
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0034493:Rabbit [Mammal]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   737 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "was"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role in Ca2+ homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "as gatekeeper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0402606:Gate-keeper [Professional or Occupational Group]
  1000   C1052868:gatekeeper [Eukaryote]

Phrase: "of active transcellular Ca2+ transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C0005529:Active Transport [Physiologic Function]
   875   C0597601:Transcellular Transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]

Phrase: "(Hoenderop et al. 1999a ,"

Phrase: "Hoenderop et al. 2000b"

Phrase: ")."
Processing 00000000.tx.21: ECaC1 protein expression is exclusively observed in 1,25-dihydroxyvitamin D3-responsive tissues, i.e., kidney and intestine (Hoenderop et al. 2000a ). 

Phrase: "ECaC1 protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1171362:protein expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "exclusively"

Phrase: "observed in 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "25-dihydroxyvitamin D3-responsive tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0040300:Tissues [Tissue]
   771 E C1547928:Tissue [Intellectual Product]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "(Hoenderop et al. 2000a"

Phrase: ")."
Processing 00000000.tx.22: In these tissues, calcium homeostasis is mainly regulated by active transepithelial transport of Ca2+ from the lumen to the blood (Friedman and Gesek 1995 ; Hoenderop et al. 2000c ), which is a three-step process consisting of passive Ca2+ entry across the apical membrane via ECaC1, cytosolic diffusion facilitated by 1,25-dihydroxyvitamin D3-dependent calcium binding proteins (calbindins), and active extrusion across the basolateral membrane (Bindels 1993 ; Hoenderop et al. 2000c ). 

Phrase: "In these tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "calcium homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "is"

Phrase: "mainly"

Phrase: "regulated by active transepithelial transport of Ca2+"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C2753390:transepithelial transport [Cell Function]
   774   C0005529:Active Transport [Physiologic Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0205177:Active [Functional Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0851285:Regulated [Governmental or Regulatory Activity]
   748   C1317949:Transport [Manufactured Object]
   748   C3495449:transport [Medical Device]

Phrase: "from the lumen"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0524461:Lumen [Body Space or Junction]
  1000   C1282864:Lumen [Body Space or Junction]
  1000   C1301906:Lumen [Qualitative Concept]
  1000   C1551056:Lumen [Quantitative Concept]
   928 E C0524462:Luminal [Spatial Concept]

Phrase: "to the blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "(Friedman"

Phrase: "and"

Phrase: "Gesek 1995"

Phrase: "; Hoenderop et al. 2000c"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "a three-step process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "consisting of passive Ca2+ entry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1705654:Entry [Intellectual Product]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "across the apical membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596119:apical membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "via ECaC1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "cytosolic diffusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0012222:Diffusion [Natural Phenomenon or Process]
   861   C1696141:Diffusion [Functional Concept]

Phrase: "facilitated by 1,"

Phrase: "25-dihydroxyvitamin D3-dependent calcium binding proteins"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   845   C0006732:Calcium-Binding Proteins [Amino Acid, Peptide, or Protein,Receptor]
   818   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1516144:Calcium Binding [Molecular Function]
   813   C0805431:Calcium/Protein [Quantitative Concept]
   812 E C1822659:calcium binding protein [Gene or Genome]
   795   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   795   C0006726:Calcium [Inorganic Chemical]
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(calbindins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054444:Calbindins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "active extrusion across the basolateral membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443213:Extrusion [Finding]

Phrase: "(Bindels 1993"

Phrase: "; Hoenderop et al. 2000c"

Phrase: ")."
Processing 00000000.tx.23: In kidney and intestine, ECaC1 expression was indeed observed in the apical membrane and co-localized with other Ca2+ transport proteins, including calbindin-D (Hoenderop et al. 2000a ). 

Phrase: "In kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "intestine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "ECaC1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "indeed"

Phrase: "observed in the apical membrane"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0596119:apical membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0205111:Apical [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1441672:Observed [Functional Concept]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "and"

Phrase: "co-localized with other Ca2+ transport proteins,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0007292:Transport Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0599895:protein transport [Cell Function]
   757 E C1159772:Protein Transport [Cell Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392752:Localized [Spatial Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1317949:Transport [Manufactured Object]
   748   C3495449:transport [Medical Device]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "calbindin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054444:Calbindin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "D ("

Phrase: "Hoenderop et al. 2000a"

Phrase: ")."
Processing 00000000.tx.24: Recently, it was shown that ECaC1 is a selective Ca2+ channel, exhibiting Ca2+-dependent autoregulation and being vitamin D-dependent (Vennekens et al. 2000 ; Hoenderop et al. 2001 ). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "a selective Ca2+ channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "Ca2+-dependent autoregulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019868:Autoregulation [Biologic Function]

Phrase: "and"

Phrase: "being"

Phrase: "vitamin D-dependent"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0851827:Dependent [Qualitative Concept]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]
   734   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   734   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   734   C2936842:Vitamin D [Pharmacologic Substance]
   734   C3537249:vitamin D [Pharmacologic Substance]

Phrase: "(Vennekens et al. 2000"

Phrase: "; Hoenderop et al. 2001"

Phrase: ")."
Processing 00000000.tx.25: Moreover, recent studies in humans demonstrated mRNA expression of ECaC1 not only in kidney and intestine but also in brain, testis, prostate, placenta, and pancreas (Muller et al. 2000 ). 

Phrase: "Moreover,"

Phrase: "recent studies in humans"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   819   C0178693:humans studies [Research Activity]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "mRNA expression of ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515670:mRNA Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "not only in kidney"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0022646:Kidney [Body Part, Organ, or Organ Component]
   770   C0205171:Only [Quantitative Concept]
   770   C0227665:kidney [Body Part, Organ, or Organ Component]
   770   C1278978:Kidney [Body Part, Organ, or Organ Component]
   770   C1514845:KIDNEY [Tissue]
   770   C1518422:Not [Functional Concept]
   770   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "but"

Phrase: "also in brain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006104:Brain [Body Part, Organ, or Organ Component]
   790   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "testis,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0039597:Testis [Body Part, Organ, or Organ Component]
  1000   C1278981:Testis [Body Part, Organ, or Organ Component]
   916 E C0021358:Testes [Body Part, Organ, or Organ Component]
   907 E C0205070:Testicular [Spatial Concept]
   888 E C1284096:Testicle [Body Part, Organ, or Organ Component]

Phrase: "prostate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033572:Prostate [Body Part, Organ, or Organ Component]
  1000   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "placenta,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0032043:Placenta [Embryonic Structure]
  1000   C1278988:Placenta [Embryonic Structure]
  1000   C1550656:Placenta [Body Substance]
   928 E C0230956:Placental [Mammal]

Phrase: "and"

Phrase: "pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "(Muller et al. 2000"

Phrase: ")."
Processing 00000000.tx.26: In pancreatic -cells, calcium plays a central role in stimulussecretion coupling and is regulated by glucose and other secretagogues. 

Phrase: "In pancreatic -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in stimulussecretion coupling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "is"

Phrase: "regulated by glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "other secretagogues."
Processing 00000000.tx.27: An increase in intracellular Ca2+ concentrations ([Ca2+]i) is necessary to induce insulin secretion (Roe et al. 1993 ), which occurs in a pulsatile and oscillatory manner coincident with intracellular calcium oscillations (Gilon et al. 1993 ). 

Phrase: "An increase in intracellular Ca2+ concentrations ([Ca2+]i)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "is"

Phrase: "necessary to"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Roe et al. 1993"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "occurs in a pulsatile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439606:Pulsatile [Temporal Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "oscillatory manner"

Phrase: "coincident with intracellular calcium oscillations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205420:Coincident [Temporal Concept]

Phrase: "(Gilon et al. 1993"

Phrase: ")."
Processing 00000000.tx.28: For this, a close interplay between plasma membrane ion channels (such as the ATP-regulated K+ channels and the voltage-gated L-type Ca2+ channels) and the secretory granules, containing high Ca2+ levels, is prerequisite (Ammala et al. 1991 ). 

Phrase: "For this,"

Phrase: "a close interplay between plasma membrane ion channels"

Phrase: "("

Phrase: "such as the ATP-regulated K+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "the voltage-gated L-type Ca2+ channels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   887   C0597675:voltage gated channel [Physiologic Function]
   766   C0439799:Channel [Spatial Concept]
   766   C1706095:Channel [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "the secretory granules,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "high Ca2+ levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "prerequisite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679209:prerequisite [Idea or Concept]

Phrase: "(Ammala et al. 1991"

Phrase: ")."
Processing 00000000.tx.29: However, it is not yet clear how the complex Ca2+-mediated transduction pathway resulting in stimulussecretion coupling occurs in the -cell and if other Ca2+ channels, such as ECaC1, can play a role in these processes. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "how"

Phrase: "the complex Ca2+-mediated transduction pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1704259:Pathway [Molecular Function]
   804   C1705987:Pathway [Conceptual Entity]

Phrase: "resulting in stimulussecretion coupling"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1948027:Coupling [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "occurs in the -cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1709305:Occur [Activity]
   770   C1948049:Cell [Spatial Concept]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "if"

Phrase: "other Ca2+ channels,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "such as ECaC1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "can"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in these processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.30: In Type 2 diabetes mellitus (Type 2 DM), glucose-induced insulin secretion is impaired. 

Phrase: "In Type 2 diabetes mellitus (Type 2 DM),"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
  1000   C2984301:Type II diabetes mellitus [Functional Concept]
   875   C1320657:type diabetes [Finding]
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0441730:Type 2 [Classification]
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0332307:Type [Qualitative Concept]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.31: Both in isolated pancreatic islets exposed to high glucose (Okamoto et al. 1992 ) and in diabetic rats (Okamoto et al. 1995 ), it was observed that this impairment was due to the inability of glucose to increase the [Ca2+]i. 

Phrase: "Both in isolated pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "exposed to high glucose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C0860803:high glucose [Finding]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "(Okamoto et al. 1992"

Phrase: ")"

Phrase: "and in diabetic rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0241863:DIABETIC [Finding]
   770   C1515981:And [Idea or Concept]

Phrase: "(Okamoto et al. 1995"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "this impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0684336:Impairment [Pathologic Function]

Phrase: "was due to the inability of glucose to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0043194:WAS [Disease or Syndrome]
   744   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1421478:WAS [Gene or Genome]
   744   C3146286:Due [Idea or Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.32: As in kidney, in pancreatic -cells Na+/Ca2+ exchanger (NCX), parathyroid hormone-related peptide (PTHrP), calbindin-D28K, and receptors for 1,25-dihydroxyvitamin D3 have been found (Clark et al. 1980 ; Drucker et al. 1989 ; Johnson et al. 1994 ; Eylen et al. 1997 ). 

Phrase: "As in kidney,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0022646:Kidney [Body Part, Organ, or Organ Component]
   790   C0227665:kidney [Body Part, Organ, or Organ Component]
   790   C1278978:Kidney [Body Part, Organ, or Organ Component]
   790   C1514845:KIDNEY [Tissue]

Phrase: "in pancreatic -cells Na+/Ca2+ exchanger"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C1272460:{NA} [Qualitative Concept]
   804   C1621574:exchanger [Molecular Function]

Phrase: "(NCX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415651:NCX [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "parathyroid hormone-related peptide"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0070099:Parathyroid Hormone-Related Peptide [Amino Acid, Peptide, or Protein,Hormone]
   861   C0030520:Parathyroid Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1882913:PARATHYROID HORMONE [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C3536885:Parathyroid Hormone [Pharmacologic Substance]
   812   C0019932:Hormone [Hormone]
   812   C0030518:Parathyroid, NOS [Body Part, Organ, or Organ Component]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0458083:Hormonal [Qualitative Concept]
   741 E C0869014:Relations [Social Behavior]

Phrase: "(PTHrP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0070099:PTHrP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1335272:PTHRP [Gene or Genome]
  1000   C1705623:PTHRP [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "calbindin-D28K,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "receptors for 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "25-dihydroxyvitamin D3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "(Clark et al. 1980"

Phrase: "; Drucker et al. 1989"

Phrase: "; Johnson et al. 1994"

Phrase: "; Eylen et al. 1997"

Phrase: ")."
Processing 00000000.tx.33: It is believed that in the -cell, NCX participates in the control of [Ca2+]i and that both NCX and PTHrP modulate insulin release (Eylen et al. 1997 ; Villanueva-Penacarrillo et al. 1999 ). 

Phrase: "It"

Phrase: "is"

Phrase: "believed"

Phrase: "that in the -cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "NCX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415651:NCX [Gene or Genome]

Phrase: "participates in the control of [Ca2+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0243148:control [Qualitative Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "that"

Phrase: "both NCX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415651:NCX [Gene or Genome]

Phrase: "and"

Phrase: "PTHrP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0070099:PTHrP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1335272:PTHRP [Gene or Genome]
  1000   C1705623:PTHRP [Gene or Genome]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Eylen et al. 1997"

Phrase: "; Villanueva-Penacarrillo et al. 1999"

Phrase: ")."
Processing 00000000.tx.34: Moreover, vitamin D has been postulated to modulate calcium metabolism of the -cell via an effect at the transcriptional level, including the production of calbindin-D28K (Lee et al. 1984 ). 

Phrase: "Moreover,"

Phrase: "vitamin D"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C2936842:Vitamin D [Pharmacologic Substance]
  1000   C3537249:vitamin D [Pharmacologic Substance]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "has"

Phrase: "been"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "calcium metabolism of the -cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0596236:calcium metabolism [Organism Function]
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]

Phrase: "via an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "at the transcriptional level,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the production of calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "(Lee et al. 1984"

Phrase: ")."
Processing 00000000.tx.35: In addition, in vitamin D-deficient rats, insulin secretion is impaired (Norman et al. 1980 ) but is restored by vitamin D treatment (Ishida et al. 1983 ). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "in vitamin D-deficient rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(Norman et al. 1980"

Phrase: ")"

Phrase: "but"

Phrase: "is"

Phrase: "restored by vitamin D treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   806   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   806   C2936842:Vitamin D [Pharmacologic Substance]
   806   C3537249:vitamin D [Pharmacologic Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "(Ishida et al. 1983"

Phrase: ")."
Processing 00000000.tx.36: Sooy et al. 

Phrase: "Sooy et al."
Processing 00000000.tx.37: 1999 suggested that calbindin-D28K could control the rate of insulin release via regulation of [Ca2+]i. 

Phrase: "1999"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the rate of insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "via regulation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.38: Altogether, this indicates that in the pancreatic -cell Ca2+ homeostasis is a complex process in which many Ca2+ transport proteins play a role. 

Phrase: "Altogether,"

Phrase: "this"

Phrase: "indicates"

Phrase: "that in the pancreatic -cell Ca2+ homeostasis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0007634:Cell [Cell]
   748   C0019868:Homeostasis [Biologic Function]
   748   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "a complex process in which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1522240:Process [Phenomenon or Process]

Phrase: "many Ca2+ transport proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0007292:Transport Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0005528:Transport, NOS [Cell Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.39: The aim of the present study was to investigate by RT-PCR and immunohistochemistry whether ECaC1 is expressed in rat pancreatic tissue. 

Phrase: "The aim of the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1947946:Aim [Idea or Concept]
   753   C2948600:Aim [Pharmacologic Substance]
   753   C3540471:AIM [Gene or Genome]
   753   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate by RT-PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C1292732:investigate [Functional Concept]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "and"

Phrase: "immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "whether"

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "expressed in rat pancreatic tissue."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.40: In our studies, we included the Zucker diabetic fatty (ZDF) rat, an animal model for Type 2 DM. 

Phrase: "In our studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the Zucker diabetic fatty"

Phrase: "(ZDF"

Phrase: ")"

Phrase: "rat,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "an animal model for Type 2 DM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0599779:Animal Model [Animal]
   744   C0003062:Animal [Animal]
   744   C3161035:Model [Intellectual Product]
Processing 00000000.tx.41: The ZDF rat becomes mildly hyperglycemic between 7 and 10 weeks of age and thereafter spontaneously develops overt diabetes (Clark et al. 1983 ; Tokuyama et al. 1995 ). 

Phrase: "The ZDF rat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Zucker rat [Mammal]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]

Phrase: "becomes"

Phrase: "mildly hyperglycemic between 7"

Phrase: "and"

Phrase: "10 weeks of age"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "thereafter spontaneously"

Phrase: "develops"

Phrase: "overt diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Clark et al. 1983"

Phrase: "; Tokuyama et al. 1995"

Phrase: ")."
Processing 00000000.tx.42: We used the ZDF rat to investigate whether ECaC1 expression is affected during the progression of diabetes. 

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ZDF rat to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0034719:Zucker rat [Mammal]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "ECaC1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "affected during the progression of diabetes."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0242656:progression [Pathologic Function]
   753   C0392760:Affected [Functional Concept]
   753   C0449258:Progression [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   719 E C0001721:Affect [Mental Process]
Processing 00000000.tx.43: We therefore studied ECaC1 expression longitudinally by IHC in control and ZDF rats 624 weeks of age. 

Phrase: "We therefore"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "ECaC1 expression longitudinally by IHC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "ZDF rats 624 weeks of age."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439230:weeks [Temporal Concept]
   711 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.44: Furthermore, we measured plasma 1,25-dihydroxyvitamin D3 levels to examine if ECaC1 expression in the pancreas is dependent on vitamin D concentrations. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "plasma 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "25-dihydroxyvitamin D3 levels to"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0441889:Levels [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "examine"

Phrase: "if"

Phrase: "ECaC1 expression in the pancreas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "dependent on vitamin D concentrations."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
Processing 00000000.tx.45: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion Literature Cited Experimental Animals Male Zucker diabetic fatty (ZDF/Gmi-fa/fa or ZDF) and lean Zucker control (ZDF/Gmi-+/? or control) rats were obtained from Genetic Models (Indianapolis, IN). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Experimental Animals Male Zucker diabetic fatty"

Phrase: "(ZDF/Gmi-fa/fa"

Phrase: "or"

Phrase: "ZDF"

Phrase: ")"

Phrase: "and"

Phrase: "lean Zucker control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(ZDF/Gmi-+/?"

Phrase: "or"

Phrase: "control) rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "obtained from Genetic Models"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
   833   C0026343:Models, Genetic [Intellectual Product]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C3161035:Models [Intellectual Product]
   737 E C1706701:Obtain [Activity]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "(Indianapolis,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.46: All rats were maintained on a 12-hr light/dark cycle (lights on at 0700, lights off at 1900 hr), and had ad libitum access to tapwater and chow (RMH-B: 22.8% protein, 5.1% fat, 4.2% fiber and 67.9% other carbohydrates; 

Phrase: "All rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "maintained on a 12-hr light/dark cycle"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   800   C2718082:Light-Dark Cycle [Temporal Concept]
           Light Cycle
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C0332582:Dark [Qualitative Concept]
   744   C1306462:Light [Functional Concept]
   744   C1314677:Maintained [Functional Concept]
   744   C1511572:Cycle [Temporal Concept]
   744   C1881376:Light [Qualitative Concept]
   711 E C0024501:Maintain [Activity]

Phrase: "(lights on"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C0023693:lights [Natural Phenomenon or Process]
   799 E C1306462:Light [Functional Concept]
   799 E C1881376:Light [Qualitative Concept]

Phrase: "at 0700,"

Phrase: "lights off"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C0023693:lights [Natural Phenomenon or Process]
   799 E C1306462:Light [Functional Concept]
   799 E C1881376:Light [Qualitative Concept]

Phrase: "at 1900 hr"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "had"

Phrase: "ad libitum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879743:ad libitum [Qualitative Concept]

Phrase: "access"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444454:Access [Spatial Concept]
  1000   C1554204:access [Idea or Concept]

Phrase: "to tapwater"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2919405:Tap water [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "(RMH-B"

Phrase: ":"

Phrase: "22.8% protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "5.1% fat,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0424612:FAT [Organism Attribute]

Phrase: "4.2% fiber"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0012173:Fiber [Food]
   827   C0225326:Fiber [Pharmacologic Substance]
   827   C0304068:Fiber [Plant]
   827   C1260603:Fiber [Plant]
   827   C1304649:Fiber [Tissue]

Phrase: "and"

Phrase: "67.9%"

Phrase: "other carbohydrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007004:Carbohydrates [Carbohydrate]

Phrase: ";"
Processing 00000000.tx.47: Hope Farms, Woerden, The Netherlands). 

Phrase: "Hope Farms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557759:farms [Geographic Area]

Phrase: "Woerden,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")."
Processing 00000000.tx.48: Animals were studied at 6, 12, and 24 weeks of age. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "studied at 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0557651:Study [Manufactured Object]
   756   C2603343:Study [Research Activity]

Phrase: "12,"

Phrase: "and"

Phrase: "24 weeks of age."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.49: For immunofluorescence studies, three control and three ZDF rats were examined at each time point. 

Phrase: "For immunofluorescence studies,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "three control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "three ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0034719:Rats, Zucker [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "examined at each time point."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C2348792:Time Point [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0332128:Examined [Finding]
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.50: All animal experiments were performed according to the principles of laboratory animal care (NIH publication no. 85-23, revised 1985) and Dutch laws on the protection of animals. 

Phrase: "All animal experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0205664:Animal Experiments [Research Activity]
   861   C0003062:Animal [Animal]
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed according to the principles of laboratory animal care"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   764   C0003064:Laboratory Animal [Animal]
   764   C0178478:animal care [Occupation or Discipline]
   742   C0003062:Animal [Animal]
   742   C0022877:Laboratory [Manufactured Object,Organization]
   742   C0680240:according [Social Behavior]
   742   C0884358:Performed [Functional Concept]
   742   C1947933:Care [Activity]
   742   C3244292:laboratory [Functional Concept]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(NIH publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034036:Publication [Intellectual Product,Manufactured Object]
   861   C0034037:Publication [Occupational Activity]
   861   C1704324:Publication [Intellectual Product]

Phrase: "no. 85-23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "1985"

Phrase: ")"

Phrase: "and"

Phrase: "Dutch laws on the protection of animals."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0023150:Laws [Regulation or Law]
   748   C0220866:laws [Regulation or Law]
   748   C0728724:laws [Regulation or Law]
   714 E C1947938:Law [Intellectual Product]
   714 E C1947939:Law [Occupation or Discipline]
Processing 00000000.tx.51: Blood Sampling and 1,25-Dihydroxyvitamin D3 Determination Blood samples for 1,25-dihydroxyvitamin D3 determinations were obtained from control and ZDF rats under isoflurane anesthesia at 6, 12, 21, and 24 weeks of age by orbital puncture and collected in precooled tubes containing dry lithiumheparin additive (30 UP U/tube; Vacutainer, Becton Dickinson, Etten-Leur, The Netherlands). 

Phrase: "Blood Sampling"
Meta Candidates (Total=17; Excluded=10; Pruned=0; Remaining=7)
  1000   C0005834:Blood sampling [Diagnostic Procedure]
  1000   C0190979:blood sampling [Diagnostic Procedure]
   983 E C0178913:Blood sample [Body Substance]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0441621:Sampling [Diagnostic Procedure]
   861   C0870078:Sampling [Idea or Concept]
   827 E C0370003:Sample [Substance]
   827 E C2347026:Sample [Conceptual Entity]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "25-Dihydroxyvitamin D3 Determination Blood samples for 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0178913:blood samples [Body Substance]
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "25-dihydroxyvitamin D3 determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680730:determinations [Governmental or Regulatory Activity]
   779 E C1148554:determination [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained from control"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1301820:Obtained [Functional Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "and"

Phrase: "ZDF rats under isoflurane anesthesia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0034719:Rats, Zucker [Mammal]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]

Phrase: "at 6,"

Phrase: "12,"

Phrase: "21,"

Phrase: "and"

Phrase: "24 weeks of age"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "by orbital puncture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033119:Puncture [Finding]
   861   C0034117:Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1881711:PUNCTURE [Phenomenon or Process]

Phrase: "and"

Phrase: "collected in precooled tubes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0175730:tubes [Medical Device]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1547937:Tubes [Intellectual Product]
   770   C1704474:Tubes [Quantitative Concept]
   737 E C1561954:tube [Conceptual Entity]
   737 E C1704730:TUBE [Medical Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "dry lithiumheparin additive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442796:Additive [Qualitative Concept]
   827   C1550602:Additive [Substance]

Phrase: "(30 UP U/tube"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0175730:Tube [Medical Device]
   770   C1547937:Tube NOS [Intellectual Product]
   770   C1561954:tube [Conceptual Entity]
   770   C1704730:TUBE [Medical Device]

Phrase: "; Vacutainer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883522:Vacutainer [Medical Device]

Phrase: "Becton Dickinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: "Etten-Leur,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")."
Processing 00000000.tx.52: Tubes were gently shaken and centrifuged for 10 min at 1500 x g (4C). 

Phrase: "Tubes"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0175730:tubes [Medical Device]
  1000   C1547937:Tubes [Intellectual Product]
  1000   C1704474:Tubes [Quantitative Concept]
   966 E C1561954:tube [Conceptual Entity]
   966 E C1704730:TUBE [Medical Device]

Phrase: "were"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "shaken"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0040822:shake [Sign or Symptom]
   966   C1883023:Shake [Activity]

Phrase: "and"

Phrase: "centrifuged for 10 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "at 1500 x g (4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.53: Plasma samples were stored at -80C until assayed. 

Phrase: "Plasma samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0444263:Plasma sample [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -80C"

Phrase: "until"

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.54: Plasma 1,25-dihydroxyvitamin D3 levels were measured using a radioreceptor assay after extraction of the samples, followed by paper chromatography as described previously (Hoof et al. 1993 ). 

Phrase: "Plasma 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "25-dihydroxyvitamin D3 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a radioreceptor assay after extraction of the samples,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034596:Radioreceptor Assay [Laboratory Procedure]
   744   C0005507:Assay [Laboratory Procedure]
   744   C0243073:assay [Qualitative Concept]
   744   C1510438:Assay [Laboratory Procedure]

Phrase: "followed by paper chromatography"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0008568:Chromatography, Paper [Laboratory Procedure]
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0008550:Chromatography [Laboratory Procedure]
   770   C0030351:Paper [Manufactured Object]
   770   C1547566:Paper [Idea or Concept]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Hoof et al. 1993"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019908:Hoof [Body Part, Organ, or Organ Component]
   812   C1455831:Hoof [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.55: RT-PCR Under isoflurane anesthesia of the rats, the pancreas was rapidly removed and cleared of fat. 

Phrase: "RT-PCR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   827   C1555029:Reverse [Idea or Concept]

Phrase: "Under isoflurane anesthesia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   861   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   745 E C0002932:Anaesthetic [Pharmacologic Substance]

Phrase: "of the rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "cleared of fat."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0424612:FAT [Organism Attribute]
   790   C0521097:cleared [Functional Concept]
   756 E C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.56: Small parts of the pancreas were immediately frozen in liquid nitrogen. 

Phrase: "Small parts of the pancreas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1292711:Part of [Spatial Concept]
   781   C1268125:Pancreas part [Body Part, Organ, or Organ Component]
   760   C0449719:parts [Spatial Concept]
   760   C1709471:PARTS [Quantitative Concept]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "frozen in liquid nitrogen."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
Processing 00000000.tx.57: For RNA isolation, the tissue was ground with a mortar and pestle that were pretreated with 70% ethanol in diethyl pyrocarbonate (DEPC; Sigma Chemical, St Louis, MO). 

Phrase: "For RNA isolation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "the tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040300:Tissue [Tissue]
  1000   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "ground with a mortar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0185051:grind [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "pestle"

Phrase: "that"

Phrase: "were"

Phrase: "pretreated with 70% ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1381542:70% Ethanol [Clinical Drug]
   770   C0001962:Ethanol [Organic Chemical]

Phrase: "in diethyl pyrocarbonate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012186:Diethyl Pyrocarbonate [Organic Chemical,Pharmacologic Substance]
   861   C0212509:pyrocarbonate [Organic Chemical]

Phrase: "(DEPC"

Phrase: "; Sigma Chemical, St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3272372:ST [Intellectual Product]

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.58: Total RNA was isolated from the resulting powder using TRIzol (Gibco BRL; Gaithersburg, MD) according to the manufacturer's instructions, except that an additional acidic phenolchloroform extraction was performed to remove excessive protein. 

Phrase: "Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from the resulting powder"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0032861:Powder [Biomedical or Dental Material]
   760   C0205409:Isolated [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1382110:Powder [Substance]
   760   C1548221:Isolated [Idea or Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRIzol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0916178:trizol [Organic Chemical]

Phrase: "(Gibco BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: "; Gaithersburg,"

Phrase: "MD) according to the manufacturer's instructions,"

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that"

Phrase: "an additional acidic phenolchloroform extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185115:Extraction [Therapeutic or Preventive Procedure]
   812   C0684295:extraction [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "excessive protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.59: For cDNA synthesis, 25 g of total RNA was incubated with 5 mU Pd(N)6 (Pharmacia; Roosendaal, The Netherlands) at 70C for 10 min. 

Phrase: "For cDNA synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "25 g of total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with 5 mU Pd(N)6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1426765:MU-5 [Gene or Genome]
   748   C0347978:Mu [Intellectual Product]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "; Roosendaal,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: "at 70C"

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.60: Thereafter, the RNA was reverse transcribed (RT) in a final volume of 20 l containing 10 mM dithiothreitol, 0.5 mM dNTPs, 40 U RNase inhibitor (Promega; Madison, WI), and 100 U of Superscript II (Gibco BRL) for 1.5 hr at 37C. 

Phrase: "Thereafter,"

Phrase: "the RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "reverse transcribed (RT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1555029:Reverse [Idea or Concept]

Phrase: "in a final volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 20 l"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "0.5 mM dNTPs,"

Phrase: "40 U RNase inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Promega"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "; Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "100 U of Superscript II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1421413:U-II [Gene or Genome]

Phrase: "(Gibco BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: "for 1.5 hr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "at 37C."
Processing 00000000.tx.61: The samples were then incubated at 70C for 10 min and subsequently diluted to a final volume of 50 l. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated at 70C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "subsequently"

Phrase: "diluted to a final volume of 50 l."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205088:Final [Temporal Concept]
   744   C0449468:*Volume [Quantitative Concept]
   744   C1546485:Final [Idea or Concept]
   744   C1690016:% volume [Qualitative Concept]
   744   C1705102:Volume [Intellectual Product]
   744   C2700258:Volume [Laboratory Procedure]
   711   C1720119:Dilute [Functional Concept]
   711   C1948037:Dilute [Functional Concept]
Processing 00000000.tx.62: For RT-PCR analysis, 2.5 l of cDNA was used as a template in a 25-l amplification mixture containing Sybr Green (PE Applied Biosystems Benelux; Nieuwerkerk a/d IJssel, The Netherlands), 1 mM dNTPs, 3 mM MgCl2, 0.6 U Taq Gold polymerase (PE Applied Biosystems) and 0.6 M of each primer. 

Phrase: "For RT-PCR analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0200931:PCR analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "2.5 l of cDNA"

Phrase: "was"

Phrase: "used as a template"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0728990:TEMPLATE [Medical Device]
   770   C1273517:used [Finding]
   770   C1514575:Template [Conceptual Entity]
   770   C1705542:Template [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "in a 25-l amplification mixture containing Sybr Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0332583:Green [Qualitative Concept]

Phrase: "(PE"

Phrase: "Applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "Biosystems Benelux"

Phrase: "; Nieuwerkerk a/d IJssel,"

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: ","

Phrase: "1 mM dNTPs,"

Phrase: "3 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "0.6 U Taq Gold polymerase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0075813:Taq Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(PE Applied Biosystems"

Phrase: ")"

Phrase: "and"

Phrase: "0.6 M of each primer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.63: The primer sets used in the PCR were: for insulin (118-bp fragment), sense 5'-gggaacgtggtttcttctacaca-3', antisense 5'-tccagtgccaaggtctgaagat-3'; 

Phrase: "The primer sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036849:Set [Mental Process]
   861   C1442518:Set [Functional Concept]
   861   C1705195:Set [Conceptual Entity]

Phrase: "used in the PCR"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: ":"

Phrase: "for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(118-bp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "sense 5'-gggaacgtggtttcttctacaca-3',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036658:sense [Organ or Tissue Function]

Phrase: "antisense 5'-tccagtgccaaggtctgaagat-3'"

Phrase: ";"
Processing 00000000.tx.64: for ECaC1 (158 bp), sense 5'-agcaatagccaccgtggatg-3', antisense 5'-atgtcccagggtgtttcgac-3'; 

Phrase: "for ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "(158 bp"

Phrase: ")"

Phrase: ","

Phrase: "sense 5'-agcaatagccaccgtggatg-3',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036658:sense [Organ or Tissue Function]

Phrase: "antisense 5'-atgtcccagggtgtttcgac-3'"

Phrase: ";"
Processing 00000000.tx.65: for calbindin-D28K (70 bp), sense 5'-ggagctgcagaacttgatccag-3', antisense 5'-ctcaggtgatagctccaatccag-3'; 

Phrase: "for calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(70 bp"

Phrase: ")"

Phrase: ","

Phrase: "sense 5'-ggagctgcagaacttgatccag-3',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036658:sense [Organ or Tissue Function]

Phrase: "antisense 5'-ctcaggtgatagctccaatccag-3'"

Phrase: ";"
Processing 00000000.tx.66: and for -actin (84 bp), sense 5'-accctaaggccaaccgtga-3', antisense 5'-cagcctggatggctacgtacat-3'. 

Phrase: "and for -actin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1515981:And [Idea or Concept]
   718 E C0439681:Actinic [Qualitative Concept]

Phrase: "(84 bp"

Phrase: ")"

Phrase: ","

Phrase: "sense 5'-accctaaggccaaccgtga-3',"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036658:sense [Organ or Tissue Function]

Phrase: "antisense 5'-cagcctggatggctacgtacat-3'."
Processing 00000000.tx.67: After an initial step at 95C for 10 min, a real-time semiquantitative PCR of 40 cycles was performed (PE Applied Biosystems), each cycle consisting of 15-sec denaturation at 95C and 1-min annealing at 60C. 

Phrase: "After an initial step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "at 95C"

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "a real-time semiquantitative PCR of 40 cycles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   744   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(PE Applied Biosystems"

Phrase: ")"

Phrase: ","

Phrase: "each cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511572:Cycle [Temporal Concept]

Phrase: "consisting of 15-sec denaturation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0301642:Denaturation [Molecular Function]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "at 95C"

Phrase: "and"

Phrase: "1-min annealing at 60C."
Processing 00000000.tx.68: Cycle threshold (CT) values were determined using the PE Applied Biosystems software. 

Phrase: "Cycle threshold (CT) values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0042295:Values [Qualitative Concept]
   827   C0449864:Threshold [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the PE"

Phrase: "Applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "Biosystems software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.69: CT is defined as the cycle number at which the amount of amplified target passes a fixed threshold above baseline. 

Phrase: "CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]

Phrase: "is"

Phrase: "defined as the cycle number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
   760   C1511572:Cycle [Temporal Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "at which"

Phrase: "the amount of amplified target"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "passes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828386:Pass [Finding]

Phrase: "a fixed threshold above baseline."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.70: As a control for the amount of RNA used, -actin was used. 

Phrase: "As a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "for the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ", -"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.71: Antisera The guinea pig anti-rabbit ECaC1 polyclonal antiserum was directed against a peptide corresponding to the 10 carboxy-terminal amino acid residues 698707 (NH2-SHRGWEILRQ -COOH) of ECaC1. 

Phrase: "Antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "The guinea pig anti-rabbit ECaC1 polyclonal antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "directed against a peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "corresponding to the 10 carboxy-terminal amino acid residues 698707"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C1707271:Carboxy-Terminal Amino Acid [Amino Acid Sequence]
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0205088:Terminal [Temporal Concept]
   739   C0596260:Carboxy [Organic Chemical]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(NH2-SHRGWEILRQ -COOH"

Phrase: ")"

Phrase: "of ECaC1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.72: Anti-insulin and anti-glucagon polyclonal antisera were obtained from Dakopatts (Copenhagen, Denmark). 

Phrase: "Anti-insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "anti-glucagon polyclonal antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "obtained from Dakopatts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(Copenhagen,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")."
Processing 00000000.tx.73: The anti-prohormone convertase 1 (PC1) polyclonal antiserum was kindly provided by Dr. 

Phrase: "The anti-prohormone convertase 1 (PC1) polyclonal antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "kindly"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.74: W.J.M. 

Phrase: "W.J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.75: Van de Ven (Leuven, Belgium) and has been extensively characterized (Jackson et al. 1997 ). 

Phrase: "Van de Ven"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0011198:DE [Geographic Area]
   827   C0017480:DE [Geographic Area]
   827   C0042469:VEN [Geographic Area]
   827   C0557775:Van [Manufactured Object]
   827   C3541240:DE [Idea or Concept]

Phrase: "(Leuven,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "extensively"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "(Jackson et al. 1997"

Phrase: ")."
Processing 00000000.tx.76: The polyclonal antiserum against calbindin-D28K was a generous gift of Dr. 

Phrase: "The polyclonal antiserum against calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "a generous gift of Dr."
Processing 00000000.tx.77: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.78: Christakos (New Jersey). 

Phrase: "Christakos"

Phrase: "(New Jersey"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027971:New Jersey [Geographic Area]
   861   C0205314:New [Temporal Concept]
   861   C0454673:Jersey [Geographic Area]

Phrase: ")."
Processing 00000000.tx.79: Antisera were diluted in TNB buffer [0.15 M NaCl, 0.1 M Tris-HCl, pH 7.5, 0.5% (w/v) blocking reagent from NEN Life Science Products (Zaventem, Belgium)]. 

Phrase: "Antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "diluted in TNB buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "[0.15 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1 M Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "0.5%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "blocking reagent from NEN Life Science Products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Zaventem,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.80: The guinea pig antiserum to ECaC1 was used at a dilution of 1:3000, the guinea pig antiserum to human insulin at 1:12,000, the rabbit antiserum to human glucagon 1:500, the rabbit antiserum to human PC1 and the rabbit antiserum to rat calbindin-D28K both at 1:600. 

Phrase: "The guinea pig antiserum to ECaC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "used at a dilution of 1"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   767   C1524063:Use of [Functional Concept]
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1273517:used [Finding]
   753   C1948037:Dilution [Functional Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "3000,"

Phrase: "the guinea pig antiserum to human insulin at 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "12,000,"

Phrase: "the rabbit antiserum to human glucagon 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ":"

Phrase: "500,"

Phrase: "the rabbit antiserum to human PC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "the rabbit antiserum to rat calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "both at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "600."
Processing 00000000.tx.81: As negative controls, pre-immune serum and TNB buffer were used instead of the primary and secondary antisera. 

Phrase: "As negative controls,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   966   C1639518:% negative control [Quantitative Concept]
   966   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "pre-immune serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0020960:immune serum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0229671:Serum [Body Substance]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "TNB buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "were"

Phrase: "used instead of the primary"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C1524063:Use of [Functional Concept]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "secondary antisera."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.82: Antiserum pre-absorbed for 1 hr with 10 g/ml ECaC1 peptide was used as a negative control for the ECaC1 antiserum. 

Phrase: "Antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "pre-absorbed for 1 hr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332152:Pre [Temporal Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C2257086:PRE [Genetic Function]

Phrase: "with 10 g/ml ECaC1 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "used as a negative control"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   806   C1639518:% negative control [Quantitative Concept]
   806   C1947986:Negative Control [Conceptual Entity]
   760   C0205160:Negative [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C1273517:used [Finding]
   760   C1513916:Negative [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825415:Negative [Conceptual Entity]
   760   C2825491:Negative [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for the ECaC1 antiserum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.83: Immunofluorescence Studies Under isoflurane anesthesia of the rats, the pancreas was rapidly removed and cleared of fat. 

Phrase: "Immunofluorescence Studies Under isoflurane anesthesia of the rats,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0016318:Immunofluorescence [Laboratory Procedure]
   744   C0079603:Immunofluorescence [Laboratory Procedure]
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "cleared of fat."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0424612:FAT [Organism Attribute]
   790   C0521097:cleared [Functional Concept]
   756 E C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.84: Small parts of the pancreas were fixed overnight at 4C in 4% phosphate-buffered formaldehyde (pH 7.4). 

Phrase: "Small parts of the pancreas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1292711:Part of [Spatial Concept]
   781   C1268125:Pancreas part [Body Part, Organ, or Organ Component]
   760   C0449719:parts [Spatial Concept]
   760   C1709471:PARTS [Quantitative Concept]

Phrase: "were"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "overnight at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439583:Overnight [Temporal Concept]
   790   C0450376:4c [Intellectual Product]

Phrase: "in 4% phosphate-buffered formaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.85: The tissues were then rinsed in PBS, dehydrated in a graded series of ethanol, rinsed in xylene two times for 30 min each, and impregnated twice for 30 min with Paraplast Plus (Oxford Labware; St Louis, MO) under vacuum. 

Phrase: "The tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "rinsed in PBS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "dehydrated in a graded series of ethanol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0001962:Ethanol [Organic Chemical]
   748   C0011175:Dehydrated [Disease or Syndrome]
   748   C0205549:Series [Quantitative Concept]
   748   C2348044:Series [Intellectual Product]

Phrase: "rinsed in xylene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "two times for 30 min"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0456693:/30 min [Temporal Concept]
   806   C1442458:30 min [Temporal Concept]
   806   C1948050:Two Times [Quantitative Concept]
   760   C0040223:times [Temporal Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0702093:/min [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "each,"

Phrase: "and"

Phrase: "impregnated"

Phrase: "twice for 30 min"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "with Paraplast"

Phrase: "Plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "(Oxford Labware"

Phrase: "; St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO) under vacuum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3538743:MO [Idea or Concept]
Processing 00000000.tx.86: Paraffin sections 4 m thick were mounted on SuperFrost Plus glass slides (Merck; Darmstadt, Germany) and kept overnight at 37C. 

Phrase: "Paraffin sections 4 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "thick"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thick [Qualitative Concept]

Phrase: "were"

Phrase: "mounted on SuperFrost Plus glass slides"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0017596:Glass [Manufactured Object]
   753   C0332287:Plus [Qualitative Concept]
   753   C0444330:slides [Research Device]
   753   C0449878:mounted [Finding]
   753   C1947936:Glass [Medical Device]
   719 E C0181909:Mount [Medical Device]
   719 E C1705201:Slide [Manufactured Object]

Phrase: "(Merck"

Phrase: "; Darmstadt,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "overnight at 37C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.87: For immunofluorescence studies, tissue sections were dewaxed with two changes of xylene, rehydrated through graded ethanol, and then washed with PBS (pH 7.4). 

Phrase: "For immunofluorescence studies,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "tissue sections"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C2316368:Tissue section [Tissue]
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "dewaxed with two changes of xylene,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0043367:Xylene [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0205448:Two [Quantitative Concept]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "rehydrated through graded ethanol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0001962:Ethanol [Organic Chemical]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed with PBS (pH 7.4"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C1882074:pH 7 [Qualitative Concept]
   783   C2678549:PH-4 [Gene or Genome]
   753   C0020283:[pH] [Quantitative Concept]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]
   753   C1548982:Washed [Idea or Concept]
   753   C1720830:PBS [Disease or Syndrome]
   753   C1823521:PBS [Gene or Genome]
   719 E C0441648:Wash [Activity]

Phrase: ")."
Processing 00000000.tx.88: Thereafter, sections were boiled for 2 min in citrate buffer (0.01 M C5H6Na3O7 and 0.01 M C6H8O7, pH 6), cooled to room temperature (RT), and thoroughly rinsed with TN buffer (0.15 M NaCl, 0.1 M Tris-HCl, pH 7.5). 

Phrase: "Thereafter,"

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "boiled for 2 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "in citrate buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3256468:citrate buffer [Pharmacologic Substance]
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(0.01 M C5H6Na3O7"

Phrase: "and"

Phrase: "0.01 M C6H8O7,"

Phrase: "pH 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "cooled to room temperature"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1547703:Room [Spatial Concept]
   737   C1548792:Cool [Qualitative Concept]

Phrase: "(RT"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "thoroughly"

Phrase: "rinsed with TN buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   737   C1701810:Rinse [Functional Concept]
   737   C1882955:Rinse [Activity]

Phrase: "(0.15 M NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1 M Tris-HCl,"

Phrase: "pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.89: Sections were incubated with TNB buffer for 30 min before overnight incubation at 4C with the primary antibodies. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated with TNB buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "before overnight incubation"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with the primary antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.90: Then the sections were rinsed three times for 5 min in TNT buffer [TN-buffer containing 0.05% (v/v) Tween-20]. 

Phrase: "Then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "three times for 5 min"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "in TNT buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "[TN-buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.05%"

Phrase: "(v/v) Tween-20"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   861   C0560268:%V/V [Quantitative Concept]
   861   C2349105:V(V) [Element, Ion, or Isotope]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "]."
Processing 00000000.tx.91: Sections stained for ECaC1 and insulin were incubated for 1 hr at RT with goat anti-guinea pig Alexa 594-conjugated anti-IgG (1:300) (Molecular Probes; Eugene, OR). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "stained for ECaC1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0439799:Channel [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1706095:Channel [Conceptual Entity]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated for 1 hr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at RT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1516077:At [Spatial Concept]
   827   C1555029:Reverse [Idea or Concept]

Phrase: "with goat anti-guinea pig Alexa 594-conjugated anti-IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   879   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300"

Phrase: ")"

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "; Eugene,"

Phrase: "OR"

Phrase: ")."
Processing 00000000.tx.92: Sections double stained for ECaC1 and glucagon were incubated with both goat anti-guinea pig Alexa 594-conjugated anti-IgG (1:300) and goat anti-rabbit Alexa 488-conjugated anti-IgG (1:300) (both from Molecular Probes). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "stained for ECaC1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0439799:Channel [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1706095:Channel [Conceptual Entity]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "with both goat anti-guinea pig Alexa 594-conjugated anti-IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   879   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300"

Phrase: ")"

Phrase: "and"

Phrase: "goat anti-rabbit Alexa 488-conjugated anti-IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   878   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300"

Phrase: ")"

Phrase: "("

Phrase: "both from Molecular Probes"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   770   C0182400:Probes [Medical Device]
   770   C0238767:Both [Spatial Concept]
   770   C1521991:Molecular [Qualitative Concept]
   770   C1706086:Both [Qualitative Concept]
   737 E C1704681:Probe [Gene or Genome]
   737 E C2347609:Probe [Chemical Viewed Functionally]
   737 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.93: The sections double stained with ECaC1 and PC1 or with ECaC1 and calbindin-D28K were incubated for 30 min at RT with pig anti-rabbit biotinylated antiserum (1:1500) (NEN Life Science Products; Boston, MA), rinsed three times in TNT buffer, and then incubated for 30 min at RT with streptavidinHRP antiserum (1:100) (NEN Life Science Products). 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "stained with ECaC1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0439799:Channel [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1706095:Channel [Conceptual Entity]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "PC1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
   901   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: "or with ECaC1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0439799:Channel [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "incubated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at RT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1516077:At [Spatial Concept]
   827   C1555029:Reverse [Idea or Concept]

Phrase: "with pig"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1135183:Pig [Mammal]
  1000   C1136016:PIG [Mammal]
  1000   C1265533:Pig [Mammal]
  1000   C1270360:Pig [Mammal]

Phrase: "anti-rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "biotinylated"

Phrase: "antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1500"

Phrase: ")"

Phrase: "(NEN Life Science Products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0332070:Life Science Products [Health Care Related Organization]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "; Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA"

Phrase: ")"

Phrase: ","

Phrase: "rinsed three times in TNT buffer,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at RT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1516077:At [Spatial Concept]
   827   C1555029:Reverse [Idea or Concept]

Phrase: "with streptavidinHRP antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "(NEN Life Science Products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0332070:Life Science Products [Health Care Related Organization]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.94: After three 5-min rinses in TNT buffer, the peroxidase was visualized by incubation with fluorescent tyramides (1:50 in amplification solution) (NEN Life Science Products) for 7 min. 

Phrase: "After three 5-min rinses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C1701810:Rinse [Functional Concept]
   779   C1882955:Rinse [Activity]

Phrase: "in TNT buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "the peroxidase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "visualized by incubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234621:Visualized [Functional Concept]

Phrase: "with fluorescent tyramides"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50 in amplification solution"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "(NEN Life Science Products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0332070:Life Science Products [Health Care Related Organization]
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: ")"

Phrase: "for 7 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.95: For detection of ECaC1, these double stained sections were incubated for 1 hr at RT with goat anti-guinea pig Alexa 594-conjugated anti-IgG (1:300) (Molecular Probes). 

Phrase: "For detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "of ECaC1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "these double stained sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated for 1 hr"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at RT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1516077:At [Spatial Concept]
   827   C1555029:Reverse [Idea or Concept]

Phrase: "with goat anti-guinea pig Alexa 594-conjugated anti-IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   879   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300"

Phrase: ")"

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.96: All sections were rinsed thoroughly with TNT buffer, rinsed in graded methanol, and mounted in Mowiol (Hoechst; Frankfurt, Germany) containing 2.5% (w/v) NaN3. 

Phrase: "All sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "rinsed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1701810:Rinse [Functional Concept]
   966   C1882955:Rinse [Activity]

Phrase: "thoroughly with TNT buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "rinsed in graded methanol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001963:Methanol [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   737   C1701810:Rinse [Functional Concept]
   737   C1882955:Rinse [Activity]

Phrase: "and"

Phrase: "mounted in Mowiol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449878:mounted [Finding]
   756 E C0181909:Mount [Medical Device]

Phrase: "(Hoechst"

Phrase: "; Frankfurt,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2.5%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450346:2 5 [Quantitative Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "NaN3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0074721:NaN3 [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.97: Photographs were taken with a Zeiss Axioskop microscope equipped for epifluorescence illumination using Kodak EPH P1600X film. 

Phrase: "Photographs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0441468:Photographs [Manufactured Object]
  1000   C1548899:Photographs [Health Care Activity]
   893 E C0031749:Photographies [Occupational Activity]

Phrase: "were"

Phrase: "taken with a Zeiss Axioskop microscope"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0181839:Microscope [Medical Device]
   753   C1706379:Microscope [Medical Device]
   753   C1883727:Taken [Conceptual Entity]
   719 E C1515187:Take [Health Care Activity]

Phrase: "equipped for epifluorescence illumination"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0023693:Illumination [Natural Phenomenon or Process]
   770   C0023700:Illumination [Human-caused Phenomenon or Process]
   770   C0684292:illumination [Laboratory Procedure]
   770   C1964256:Illumination [Diagnostic Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Kodak EPH P1600X film."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0086296:Film [Manufactured Object]
   812   C1561571:film [Biomedical or Dental Material]
   812   C1561572:film [Substance]
Processing 00000000.tx.98: Results Top Summary Introduction Materials and Methods Results Discussion Literature Cited ECaC1 mRNA Expression in Rat Pancreatic Tissue To establish if ECaC1 is expressed in the rat pancreas, we performed RT-PCR analysis on RNA isolated from total pancreatic tissue of 6-week-old control and ZDF rats. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "ECaC1 mRNA Expression in Rat Pancreatic Tissue To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1515670:mRNA Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "if"

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "expressed in the rat pancreas,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "RT-PCR analysis on RNA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0200931:PCR analysis [Laboratory Procedure]
   783   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "isolated from total pancreatic tissue of 6-week-old control"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   757   C2983684:Total Tissue [Body Substance]
   739   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   739   C0040300:Tissue [Tissue]
   739   C0205409:Isolated [Functional Concept]
   739   C0243148:control [Qualitative Concept]
   739   C0332174:/week [Temporal Concept]
   739   C0439175:% total [Quantitative Concept]
   739   C0439230:week [Temporal Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C0580836:Old [Temporal Concept]
   739   C1547928:Tissue [Intellectual Product]
   739   C1548221:Isolated [Idea or Concept]
   739   C1550141:Control [Substance]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]
   706 E C0370215:Isolate [Substance]
   706 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "ZDF rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
Processing 00000000.tx.99: In addition, mRNA expression of insulin and calbindin-D28K was analyzed in the pancreas of both control and ZDF rats. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "mRNA expression of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1515670:mRNA Expression [Genetic Function]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "analyzed in the pancreas of both control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   748   C0243148:control [Qualitative Concept]
   748   C0936012:Analyzed [Research Activity]
   748   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "ZDF rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
Processing 00000000.tx.100: In control rats, mRNA expression was found for ECaC1 (CT 33  1), insulin (CT 21  1), calbindin-D28K (CT 34  1), and -actin (CT 22  1). 

Phrase: "In control rats,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515670:mRNA Expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "found for ECaC1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0150312:Found [Quantitative Concept]
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0439799:Channel [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1706095:Channel [Conceptual Entity]
   726 E C0243095:Find [Finding]

Phrase: "(CT 33  1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449864:Threshold [Qualitative Concept]
   812   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(CT 21  1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449864:Threshold [Qualitative Concept]
   812   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(CT 34  1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449864:Threshold [Qualitative Concept]
   812   C1511572:Cycle [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "(CT 22  1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449864:Threshold [Qualitative Concept]
   812   C1511572:Cycle [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.101: In addition, between control and ZDF rats no significant differences in CT values were observed, suggesting that mRNA expression levels of these proteins were similar in both rat strains. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "between control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "no significant differences in CT values"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   732   C0012213:Differential Threshold [Quantitative Concept]
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that mRNA expression levels of these proteins"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C1515670:mRNA Expression [Genetic Function]
   757   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Levels [Qualitative Concept]
   745   C3244092:expression level [Idea or Concept]
   741   C0428479:Protein level [Laboratory or Test Result]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "similar in both rat strains."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.102: No amplification was found when the RT step was omitted or in the water controls. 

Phrase: "No amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "when"

Phrase: "the RT step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "was"

Phrase: "omitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]

Phrase: "or in the water controls."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   760   C0599638:WATER [Substance]
   760   C1550678:Water [Inorganic Chemical]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.103: Analysis of -actin mRNA was used as a control for RNA isolation and cDNA synthesis. 

Phrase: "Analysis of -actin mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "used as a control"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "for RNA isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "cDNA synthesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]
Processing 00000000.tx.104: Immunofluorescence Localization of ECaC1 in Rat Pancreatic Islets To localize ECaC1 protein expression in pancreatic tissue, immunofluorescence experiments were performed. 

Phrase: "Immunofluorescence Localization of ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in Rat Pancreatic Islets To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "localize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:localize [Spatial Concept]

Phrase: "ECaC1 protein expression in pancreatic tissue,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1171362:protein expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "immunofluorescence experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.105: In the rat pancreas, identical labelling patterns were found for ECaC1 and insulin, i.e., immunopositive staining was present in the pancreatic islets, whereas no staining was observed in the exocrine pancreas (Fig 1A). 

Phrase: "In the rat pancreas,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "identical labelling patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "found for ECaC1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0150312:Found [Quantitative Concept]
   760   C0221908:Epithelial [Qualitative Concept]
   760   C0439799:Channel [Spatial Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1706095:Channel [Conceptual Entity]
   726 E C0243095:Find [Finding]

Phrase: "and"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "immunopositive staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "present in the pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "whereas"

Phrase: "no staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "observed in the exocrine pancreas"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0553695:Exocrine pancreas [Body Part, Organ, or Organ Component]
   806   C1280431:Exocrine pancreas [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   760   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]

Phrase: "(Fig 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.106: At higher magnification, punctate ECaC1 and insulin staining was found within the cytoplasm of the endocrine cells, suggesting a localization of ECaC1 in the secretory granules of the -cells (Fig 1B). 

Phrase: "At higher magnification,"

Phrase: "punctate ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439799:Channel [Spatial Concept]
   812   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "insulin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "found within the cytoplasm of the endocrine cells,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0229525:Endocrine Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0010834:Cytoplasm [Cell Component]
   744   C0014136:Endocrine [Body System]
   744   C0150312:Found [Quantitative Concept]
   744   C0521425:Endocrine [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C0243095:Find [Finding]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a localization of ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in the secretory granules"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "of the -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.107: Sections incubated with ECaC1 antiserum pre-absorbed for 1 hr with ECaC1 peptide or pre-immune antiserum were devoid of any immunostaining (Fig 2D, left and middle columns). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "incubated with ECaC1 antiserum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0221908:Epithelial [Qualitative Concept]
   753   C0439799:Channel [Spatial Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1706095:Channel [Conceptual Entity]

Phrase: "pre-absorbed for 1 hr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332152:Pre [Temporal Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C2257086:PRE [Genetic Function]

Phrase: "with ECaC1 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "pre-immune antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "devoid of any"

Phrase: "immunostaining"

Phrase: "(Fig 2D, left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: "and"

Phrase: "middle columns"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0599459:middle column [Body Part, Organ, or Organ Component]
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.108: View larger version (161K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(161K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.109: Immunofluorescence staining of ECaC and insulin in rat pancreatic islets. 

Phrase: "Immunofluorescence staining of ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "insulin in rat pancreatic islets."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.110: ECaC and insulin staining is present in the cytoplasm of cells in the pancreatic islets and absent in the exocrine pancreatic cells (A). 

Phrase: "ECaC"

Phrase: "and"

Phrase: "insulin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "present in the cytoplasm of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "in the pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "absent in the exocrine pancreatic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:Absent [Quantitative Concept]
   753   C2699517:ABSENT [Finding]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.111: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.112: At higher magnification (B), the staining in the endocrine cells appears to be punctate, both for insulin and ECaC. 

Phrase: "At higher magnification"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the staining in the endocrine cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "punctate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205330:Punctate [Qualitative Concept]

Phrase: "both for insulin"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0238767:Both [Spatial Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C1706086:Both [Qualitative Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "ECaC."
Processing 00000000.tx.113: Bars = 10 m. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "= 10 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.114: View larger version (30K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(30K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413114:30K [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.115: Double immunofluorescence staining in rat pancreatic islets of ECaC with glucagon, prohormone convertase 1 (PC1) and calbindin-D28K. 

Phrase: "Double immunofluorescence staining in rat pancreatic islets of ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0487602:Staining [Laboratory Procedure]
   742   C1704680:Staining [Finding]

Phrase: "with glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "prohormone convertase 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
   901   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: "(PC1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
   901   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: ")"

Phrase: "and"

Phrase: "calbindin-D28K."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.116: ECaC staining was observed in the -cells and glucagon staining in the -cells. 

Phrase: "ECaC staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "observed in the -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "glucagon staining in the -cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.117: No co-localization of ECaC and glucagon was found, as shown by the superimposed picture (A). 

Phrase: "No co-localization of ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "as"

Phrase: "shown by the superimposed picture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441468:picture [Manufactured Object]
   760   C0441469:Picture [Manufactured Object]
   726   C1547282:Show [Intellectual Product]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.118: PC1 staining was observed in the pancreatic -cells. 

Phrase: "PC1 staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0487602:Staining [Laboratory Procedure]
   812   C1704680:Staining [Finding]
   756   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]

Phrase: "was"

Phrase: "observed in the pancreatic -cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.119: The co-localization of ECaC and PC1 was highlighted by the yellow color in the -cells in the superimposed picture (B). 

Phrase: "The co-localization of ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "PC1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
   901   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: "was"

Phrase: "highlighted by the yellow color"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0221205:Yellow color [Qualitative Concept]
           Yellow
   806   C0863146:Yellow color [Qualitative Concept]
   760   C0009393:Color [Natural Phenomenon or Process]
   760   C1550604:color [Indicator, Reagent, or Diagnostic Aid]
   760   C1705245:Color [Pharmacologic Substance]

Phrase: "in the -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "in the superimposed picture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441468:picture [Manufactured Object]
   861   C0441469:Picture [Manufactured Object]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.120: Calbindin-D28K staining was present in both - and -cells, the most intense staining being found in the -cells. 

Phrase: "Calbindin-D28K staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "present in both -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "and -"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "the most intense staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "being"

Phrase: "found in the -cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0150312:Found [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.121: The superimposed picture revealed co-localization of ECaC and calbindin-D28K in the -cells (C). 

Phrase: "The superimposed picture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441468:picture [Manufactured Object]
   861   C0441469:Picture [Manufactured Object]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "co-localization of ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "calbindin-D28K in the -cells (C)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.122: Sections incubated with ECaC1 antiserum pre-absorbed for 1 hr with ECaC1 peptide (D, left) or pre-immune antiserum (D, middle). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "incubated with ECaC1 antiserum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0221908:Epithelial [Qualitative Concept]
   753   C0439799:Channel [Spatial Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1706095:Channel [Conceptual Entity]

Phrase: "pre-absorbed for 1 hr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0332152:Pre [Temporal Concept]
   760   C0740175:Pre [Qualitative Concept]
   760   C2257086:PRE [Genetic Function]

Phrase: "with ECaC1 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "pre-immune antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.123: Control was performed in which as secondary antibody a goat anti-rabbit IgG was employed in combination with the guinea pig anti-ECaC1 antibody as the primary antibody (D, right). 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "performed in which"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0034493:Rabbit [Mammal]

Phrase: "was"

Phrase: "employed in combination"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205195:Combination [Qualitative Concept]
   790   C0557351:Employed [Finding]
   790   C1947911:Combination [Physical Object]
   756 E C0457083:Employ [Functional Concept]

Phrase: "with the guinea pig anti-ECaC1 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   868   C0312627:Anti epithelial antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Epithelial antibody
   861   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as the primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.124: Bars = 25 m. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "= 25 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.125: To analyze in more detail the localization of ECaC1 in the pancreatic islets, we performed double immunofluorescence studies. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "analyze in more detail"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1522508:Detail [Qualitative Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "the localization of ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in the pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "double immunofluorescence studies."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   827   C0016318:Immunofluorescence [Laboratory Procedure]
   827   C0079603:Immunofluorescence [Laboratory Procedure]
   827   C0205173:Double [Functional Concept]
   827   C0947630:studies [Laboratory Procedure]
   827   C1705764:Double [Activity]
   827   C1705765:Double [Qualitative Concept]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   771 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   755 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.126: Labeling of rat pancreatic tissue with anti-ECaC1 and anti-glucagon antibodies revealed that ECaC1 did not co-localize with glucagon, indicating that ECaC1 is not expressed in pancreatic -cells (Fig 2A). 

Phrase: "Labeling of rat pancreatic tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "with anti-ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439799:Channel [Spatial Concept]
   812   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "anti-glucagon antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "co-localize with glucagon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0392752:localize [Spatial Concept]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "indicating"

Phrase: "that ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressed in pancreatic -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig 2A"

Phrase: ")."
Processing 00000000.tx.127: Double immunofluorescence experiments showed complete co-localization in the -cells of ECaC1 and PC1, a neuroendocrine endoprotease expressed in secretory granules (Fig 2B). 

Phrase: "Double immunofluorescence experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "complete co-localization in the -cells of ECaC1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C1660153:localisation of cell [Biologic Function]
           cell localization
   739   C0475264:Localisation [Functional Concept]
   739   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "PC1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
   901   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: "a neuroendocrine endoprotease"

Phrase: "expressed in secretory granules"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0886515:Secretory Granules [Cell Component]
   799 E C3271154:Secretory Granule [Cell Component]
   770   C0010837:Granules [Cell Component]
   770   C0993609:Granules [Biomedical or Dental Material]
   770   C1327616:Secretory [Cell Function]

Phrase: "(Fig 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.128: In agreement with previous studies (Bourlon et al. 1996 ), calbindin-D28K staining was detected in both - and -cells, with the clearest staining being found in the -cells. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "(Bourlon et al. 1996"

Phrase: ")"

Phrase: ","

Phrase: "calbindin-D28K staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected in both -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and -"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "with the clearest staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "being"

Phrase: "found in the -cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0150312:Found [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.129: Double staining of ECaC1 with calbindin-D28K revealed their co-localization in the -cells but not in the -cells, suggesting that, in the pancreas, ECaC1 expression is restricted to the -cells (Fig 2C). 

Phrase: "Double staining of ECaC1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0205173:Double [Functional Concept]
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "their co-localization in the -cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1660153:cell localization [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "but"

Phrase: "not in the -cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1518422:Not [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "in the pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "ECaC1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "restricted to the -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0443288:Restricted [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig 2C"

Phrase: ")."
Processing 00000000.tx.130: A control was performed in which as secondary antibody a goat anti-rabbit IgG was employed in combination with the guinea pig anti-ECaC1 antibody as the primary antibody to detect possible crossreactivity (Fig 2D, right). 

Phrase: "A control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "performed in which"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "a goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0034493:Rabbit [Mammal]

Phrase: "was"

Phrase: "employed in combination"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205195:Combination [Qualitative Concept]
   790   C0557351:Employed [Finding]
   790   C1947911:Combination [Physical Object]
   756 E C0457083:Employ [Functional Concept]

Phrase: "with the guinea pig anti-ECaC1 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   868   C0312627:Anti epithelial antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Epithelial antibody
   861   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as the primary antibody to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "possible crossreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010357:Cross Reactivity [Molecular Function]
   861   C0872139:cross reactivity [Molecular Function]
   861   C1880190:CROSS REACTIVITY [Event]

Phrase: "(Fig 2D, right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.131: No immunopositive staining was observed under these experimental conditions and crossreactivity can therefore be excluded. 

Phrase: "No immunopositive staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "observed under these experimental conditions"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C1441672:Observed [Functional Concept]
   760   C1517586:Experimental [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "and"

Phrase: "crossreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010357:Cross Reactivity [Molecular Function]
  1000   C0872139:cross reactivity [Molecular Function]
  1000   C1880190:CROSS REACTIVITY [Event]

Phrase: "can"

Phrase: "therefore"

Phrase: "be"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.132: ECaC1 Expression During the Progression of Diabetes in ZDF Rats Because glucose-induced insulin secretion is impaired in Type 2 DM, probably due to the inability of glucose to increase intracellular Ca2+ concentrations, we studied the expression of ECaC1 in ZDF rats, an animal model for Type 2 DM. 

Phrase: "ECaC1 Expression During the Progression of Diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in ZDF Rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "Because"

Phrase: "glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "impaired in Type 2 DM,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   882   C0011860:Diabetes Mellitus, Type 2 [Disease or Syndrome]
           Type 2 Diabetes
   882   C2984301:Type II diabetes mellitus [Functional Concept]
   790   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   790   C0441730:Type 2 [Classification]
   783   C1320657:Diabetes type [Finding]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0221099:Impaired [Functional Concept]
   753   C0332307:Type [Qualitative Concept]
   753   C0684336:Impaired [Pathologic Function]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "probably due to the inability of glucose to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0750492:Probably [Idea or Concept]
   744   C3146286:Due [Idea or Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "intracellular Ca2+ concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the expression of ECaC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in ZDF rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "an animal model for Type 2 DM."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0599779:Animal Model [Animal]
   744   C0003062:Animal [Animal]
   744   C3161035:Model [Intellectual Product]
Processing 00000000.tx.133: In control rats between 6 and 24 weeks of age, no difference in the amount of immunostaining of both ECaC1 and insulin was observed (Fig 3A). 

Phrase: "In control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "between 6"

Phrase: "and"

Phrase: "24 weeks of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "no difference in the amount of immunostaining of both ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C1705241:*Difference [Quantitative Concept]
   736   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig 3A"

Phrase: ")."
Processing 00000000.tx.134: In 6-week-old ZDF rats, the amount of ECaC1 and insulin staining was about the same as that in control rats of the same age (Fig 3B). 

Phrase: "In 6-week-old ZDF rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0034719:Rats, Zucker [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]

Phrase: "the amount of ECaC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "insulin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "about"

Phrase: "the same as that"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1278655:SAME AS [Classification]
   770   C0445247:Same [Qualitative Concept]

Phrase: "in control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "of the same age (Fig 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0450365:3b [Intellectual Product]
   812   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.135: However, in ZDF rats, aging affected the staining patterns of both ECaC1 and insulin, i.e., from 12 weeks onwards a decrease in the amount of immunostaining of these two proteins was observed. 

Phrase: "However,"

Phrase: "in ZDF rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the staining patterns of both ECaC1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   782   C0449778:Pattern of staining [Spatial Concept]
           patterns staining
   744   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "from 12 weeks onwards"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439230:weeks [Temporal Concept]
   793 E C0332174:/week [Temporal Concept]

Phrase: "a decrease in the amount of immunostaining of these two proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.136: At 24 weeks of age the amount of insulin staining had progressively decreased in the ZDF rat compared to that in 6-week-old ZDF rats. 

Phrase: "At 24 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "the amount of insulin staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "had"

Phrase: "progressively"

Phrase: "decreased in the ZDF rat"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   774   C0034719:Zucker rat [Mammal]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0241863:DIABETIC [Finding]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C2700303:Zucker [Mammal]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in 6-week-old ZDF rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0034719:Rats, Zucker [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]
Processing 00000000.tx.137: Remarkably, the amount of immunostaining of ECaC1 in 24-week-old ZDF rats was also decreased compared to the 6-week-old ZDF rats (Fig 3B). 

Phrase: "Remarkably,"

Phrase: "the amount of immunostaining of ECaC1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1265611:Amount [Quantitative Concept]

Phrase: "in 24-week-old ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0034719:Rats, Zucker [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "also"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared to the 6-week-old ZDF rats"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C0034719:Rats, Zucker [Mammal]
   739   C0034693:rats [Mammal]
   739   C0034721:Rats [Mammal]
   739   C0241863:DIABETIC [Finding]
   739   C0332174:/week [Temporal Concept]
   739   C0439230:week [Temporal Concept]
   739   C0580836:Old [Temporal Concept]
   739   C1707455:Compared [Activity]
   739   C2700303:Zucker [Mammal]

Phrase: "(Fig 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.138: View larger version (65K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(65K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.139: Immunofluorescence staining of ECaC and insulin in pancreatic islets of 6-week- and 24-week-old control (A) and 6-week- and 24-week-old ZDF (B) rats. 

Phrase: "Immunofluorescence staining of ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and"

Phrase: "insulin in pancreatic islets of 6-week-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "and"

Phrase: "24-week-old control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "6-week-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/week [Temporal Concept]
   861   C0439230:week [Temporal Concept]

Phrase: "and"

Phrase: "24-week-old ZDF"

Phrase: "(B) rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.140: In the control rats, aging did not have an effect on the amount of immunostaining of both ECaC and insulin (A). 

Phrase: "In the control rats,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "an effect on the amount of immunostaining of both ECaC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.141: However, in the -cells of 24-week-old ZDF rats the amount of staining of both ECaC and insulin was decreased compared to that in 6-week-old ZDF rats (B). 

Phrase: "However,"

Phrase: "in the -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "of 24-week-old ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0034719:Rats, Zucker [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]

Phrase: "the amount of staining of both ECaC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in 6-week-old ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0034719:Rats, Zucker [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.142: Bars = 25 m. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "= 25 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.143: Plasma 1,25-Dihydroxyvitamin D3 Concentrations in Control and ZDF Rats To establish if the reduction of ECaC1 expression in the ZDF rats was accompanied by a change in 1,25-dihydroxyvitamin D3 levels, we measured plasma vitamin D concentrations in both control and ZDF rats from 6 to 24 weeks of age. 

Phrase: "Plasma 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "25-Dihydroxyvitamin D3 Concentrations in Control"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "ZDF Rats To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0034719:Rats, Zucker [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "if"

Phrase: "the reduction of ECaC1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "accompanied by a change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "in 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "25-dihydroxyvitamin D3 levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "plasma vitamin D concentrations in both control"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0683150:concentrations plasma [Quantitative Concept]
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "ZDF rats from 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0034719:Rats, Zucker [Mammal]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]

Phrase: "to 24 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.144: Plasma 1,25-dihydroxyvitamin D3 levels were identical in control and ZDF rats and decreased with aging (Fig 4). 

Phrase: "Plasma 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "25-dihydroxyvitamin D3 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "identical in control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "and"

Phrase: "ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "decreased with aging"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0001811:Ageing [Organism Function]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.145: At 6 weeks of age, in control and ZDF rats 1,25-dihydroxyvitamin D3 levels were 548  15 pmol/liter and 556  27 pmol/liter, respectively. 

Phrase: "At 6 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "ZDF rats 1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0034719:Rats, Zucker [Mammal]
   823   C1514732:Rat-1 [Cell]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C0241863:DIABETIC [Finding]
   804   C2700303:Zucker [Mammal]

Phrase: "25-dihydroxyvitamin D3 levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "548  15 pmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0475211:liter [Quantitative Concept]

Phrase: "and"

Phrase: "556  27 pmol/liter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0475211:liter [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.146: These levels decreased progressively to 295  26 pmol/liter and 320  20 pmol/liter in control and ZDF rats of 24 weeks of age, respectively, showing that although a decrease in plasma vitamin D concentrations was observed in the ZDF rats, the decrease in ECaC1 expression in these rats was not due to a reduction in vitamin D levels (Fig 4). 

Phrase: "These levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "progressively to 295  26 pmol/liter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439192:pmol [Quantitative Concept]
   753   C0475211:liter [Quantitative Concept]

Phrase: "and"

Phrase: "320  20 pmol/liter in control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0475211:liter [Quantitative Concept]

Phrase: "and"

Phrase: "ZDF rats of 24 weeks of age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0034719:Rats, Zucker [Mammal]
   742   C0034693:rats [Mammal]
   742   C0034721:Rats [Mammal]

Phrase: "respectively,"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "although"

Phrase: "a decrease in plasma vitamin D concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "observed in the ZDF rats,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0034719:Rats, Zucker [Mammal]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0241863:DIABETIC [Finding]
   748   C1441672:Observed [Functional Concept]
   748   C2700303:Zucker [Mammal]

Phrase: "the decrease in ECaC1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in these rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "not due to a reduction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C1518422:Not [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "in vitamin D levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   901   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C2936842:Vitamin D [Pharmacologic Substance]
   901   C3537249:vitamin D [Pharmacologic Substance]
   896   C0428580:Vitamin level [Laboratory Procedure]
   896   C1318188:vitamin level [Laboratory or Test Result]
   827   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.147: View larger version (12K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.148: Plasma levels of 1,25-dihydroxyvitamin D3 in control (open circles) and ZDF (filled circles) rats between 6 and 24 weeks of age. 

Phrase: "Plasma levels of 1,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0456947:Level 1 [Intellectual Product]
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "25-dihydroxyvitamin D3 in control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]

Phrase: "(open circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "and"

Phrase: "ZDF"

Phrase: "(filled circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1282913:Circle [Spatial Concept]
   827   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "rats between 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "24 weeks of age."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.149: Data are presented as mean  SEM (four or five animals). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as mean  SEM (four"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205450:Four [Quantitative Concept]
   760   C0444504:Mean [Quantitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "or"

Phrase: "five animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: ")."
Processing 00000000.tx.150: Discussion Top Summary Introduction Materials and Methods Results Discussion Literature Cited In pancreatic -cells, calcium plays an important role in insulin secretion since an increase in [Ca2+]i is a prerequisite to facilitate stimulussecretion coupling. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited In pancreatic -cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "since"

Phrase: "an increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "a prerequisite to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679209:prerequisite [Idea or Concept]

Phrase: "facilitate"

Phrase: "stimulussecretion coupling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1948027:Coupling [Functional Concept]
Processing 00000000.tx.151: At present, the complex calcium-mediated transduction pathway in the -cells is not clear, but a close interplay between plasma membrane ion channels and secretory granules may be needed (Ammala et al. 1991 ). 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "the complex calcium-mediated transduction pathway in the -cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "a close interplay between plasma membrane ion channels"

Phrase: "and"

Phrase: "secretory granules"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "(Ammala et al. 1991"

Phrase: ")."
Processing 00000000.tx.152: In this respect, our new finding that the epithelial Ca2+ channel ECaC1 is expressed in the endocrine pancreatic islets is of interest. 

Phrase: "In this respect,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respect [Social Behavior]

Phrase: "our new finding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1268649:New finding [Finding]
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the epithelial Ca2+ channel ECaC1"

Phrase: "is"

Phrase: "expressed in the endocrine pancreatic islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   753   C0014136:Endocrine [Body System]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0521425:Endocrine [Functional Concept]

Phrase: "is of interest."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0543488:Interest [Mental Process]
Processing 00000000.tx.153: Thus far, ECaC1 expression was mainly observed at the apical membrane of 1,25-dihydroxyvitamin D3-responsive tissues, i.e., in kidney and intestine (Hoenderop et al. 2000a ). 

Phrase: "Thus far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "ECaC1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "mainly"

Phrase: "observed at the apical membrane of 1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0596119:apical membrane [Cell Component]
   748   C0025255:Membrane [Tissue]
   748   C0205111:Apical [Spatial Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1441672:Observed [Functional Concept]
   748   C1706182:Membrane [Manufactured Object]

Phrase: "25-dihydroxyvitamin D3-responsive tissues,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0040300:Tissues [Tissue]
   771 E C1547928:Tissue [Intellectual Product]

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "intestine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]

Phrase: "(Hoenderop et al. 2000a"

Phrase: ")."
Processing 00000000.tx.154: In the cytoplasm of the -cells, the immunostaining of both ECaC1 and insulin was punctate, suggesting that ECaC1 is expressed in secretory granules, probably in the granular membrane. 

Phrase: "In the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "of the -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "the immunostaining of both ECaC1"

Phrase: "and"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "punctate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205330:Punctate [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "expressed in secretory granules,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0886515:Secretory Granules [Cell Component]
   799 E C3271154:Secretory Granule [Cell Component]
   770   C0010837:Granules [Cell Component]
   770   C0993609:Granules [Biomedical or Dental Material]
   770   C1327616:Secretory [Cell Function]

Phrase: "probably in the granular membrane."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0010837:Granular [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0205248:Granular [Qualitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C0750492:Probably [Idea or Concept]
   760   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.155: In addition, ECaC1 co-localized with PC1, an endoprotease present in secretory granules and involved in the conversion of proinsulin to insulin (Bailyes et al. 1992 ). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "co-localized with PC1,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
   790   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0301817:Prohormone [Hormone]
   753   C0392752:Localized [Spatial Concept]

Phrase: "an endoprotease present in secretory granules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "involved in the conversion of proinsulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439836:Conversion [Functional Concept]
   753   C1314939:Involved [Functional Concept]

Phrase: "to insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Bailyes et al. 1992"

Phrase: ")."
Processing 00000000.tx.156: In contrast, in kidney and intestine ECaC1 is localized to the plasma membrane (Hoenderop et al. 2000a ). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "in kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0022646:Kidney [Body Part, Organ, or Organ Component]
  1000   C0227665:kidney [Body Part, Organ, or Organ Component]
  1000   C1278978:Kidney [Body Part, Organ, or Organ Component]
  1000   C1514845:KIDNEY [Tissue]
   907 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "intestine ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439799:Channel [Spatial Concept]
   812   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "localized to the plasma membrane"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0392752:Localized [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "(Hoenderop et al. 2000a"

Phrase: ")."
Processing 00000000.tx.157: Our observation that in pancreatic -cells ECaC1 expression is restricted to secretory granules suggests that it might play a role in the regulation of endocrine Ca2+ homeostasis. 

Phrase: "Our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that in pancreatic -cells ECaC1 expression"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   767   C0014597:Epithelial Cells [Cell]
   767   C1273342:Epithelial Cells [Laboratory Procedure]
   744   C0007634:Cells [Cell]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0221908:Epithelial [Qualitative Concept]
   744   C0439799:Channel [Spatial Concept]
   744   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1706095:Channel [Conceptual Entity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "restricted to secretory granules"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0886515:Secretory Granules [Cell Component]
   799 E C3271154:Secretory Granule [Cell Component]
   770   C0010837:Granules [Cell Component]
   770   C0443288:Restricted [Functional Concept]
   770   C0993609:Granules [Biomedical or Dental Material]
   770   C1327616:Secretory [Cell Function]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the regulation of endocrine Ca2+ homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.158: The secretory granules of -cells contain high levels of Ca2+ implicated in the sorting and processing of precursor proteins (Davidson et al. 1988 ). 

Phrase: "The secretory granules of -cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   886   C1519221:Secretory cell [Cell]
   841   C0596630:granule cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "high levels of Ca2+"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "implicated in the sorting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237886:Sorting [Mental Process]
   770   C0700314:sorting [Cell Function]
   770   C1947906:Sorting [Activity]

Phrase: "and"

Phrase: "processing of precursor proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0033666:protein processing [Molecular Function]
   770   C1709694:Processing [Activity]

Phrase: "(Davidson et al. 1988"

Phrase: ")."
Processing 00000000.tx.159: In the pancreatic -cell, ECaC1 may serve as an efflux pathway for Ca2+ from the secretory granules into the cytoplasm to increase [Ca2+]i. 

Phrase: "In the pancreatic -cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "may"

Phrase: "serve as an efflux pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "for Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from the secretory granules"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "into the cytoplasm to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010834:Cytoplasm [Cell Component]
   789 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.160: Increased cytoplasmic Ca2+ concentrations play an essential role in triggering exocytosis (Bokvist et al. 1995 ). 

Phrase: "Increased cytoplasmic Ca2+ concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an essential role in triggering exocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "(Bokvist et al. 1995"

Phrase: ")."
Processing 00000000.tx.161: To release Ca2+ via an efflux pathway, hyperpolarization of the granular membrane would be needed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "via an efflux pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "hyperpolarization of the granular membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C2262820:membrane hyperpolarization [Cell Function]

Phrase: "would"

Phrase: "be"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.162: In this respect it is interesting to note that hyperpolarization of the Xenopus laevis oocyte plasma membrane indeed allows Ca2+ transport via ECaC1 (Hoenderop et al. 1999b ). 

Phrase: "In this respect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respect [Social Behavior]

Phrase: "it"

Phrase: "is"

Phrase: "interesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:interesting [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that hyperpolarization of the Xenopus laevis oocyte plasma membrane indeed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   757   C2262820:membrane hyperpolarization [Cell Function]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "Ca2+ transport via ECaC1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: "(Hoenderop et al. 1999b"

Phrase: ")."
Processing 00000000.tx.163: In an alternative mechanism, ECaC1 may act at the plasma membrane after the exocytotic event, e.g., providing an influx pathway for extracellular Ca2+ to retain high cytoplasmic Ca2+ concentrations. 

Phrase: "In an alternative mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "may"

Phrase: "act at the plasma membrane"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "after the exocytotic event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "e.g."

Phrase: ","

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "an influx pathway for extracellular Ca2+ to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "high cytoplasmic Ca2+ concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.164: Clearly, further studies are needed to establish the exact role of ECaC1 in the pancreatic -cell. 

Phrase: "Clearly,"

Phrase: "further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the exact role of ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the pancreatic -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.165: In pancreatic -cells, the maintenance of intracellular Ca2+ homeostasis is a complex process because in these cells many proteins, such as NCX, PTHrP, calbindin-D28K, receptors for 1,25-dihydroxyvitamin D3, and now also ECaC1, have been found that are postulated to play a role in Ca2+ homeostasis and insulin release. 

Phrase: "In pancreatic -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the maintenance of intracellular Ca2+ homeostasis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0024501:Maintenance [Activity]

Phrase: "is"

Phrase: "a complex process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "because in these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "many proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "such as NCX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1415651:NCX [Gene or Genome]

Phrase: "PTHrP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0070099:PTHrP [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1335272:PTHRP [Gene or Genome]
  1000   C1705623:PTHRP [Gene or Genome]

Phrase: "calbindin-D28K,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "receptors for 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "25-dihydroxyvitamin D3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]

Phrase: "and"

Phrase: "now also ECaC1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439799:Channel [Spatial Concept]
   804   C1706095:Channel [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "are"

Phrase: "postulated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in Ca2+ homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "insulin release."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.166: On the basis of the analysis of calbindin-D28K knockout mice, Sooy et al. 

Phrase: "On the basis of the analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of calbindin-D28K knockout mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0206745:Knock-out Mice [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "Sooy et al."
Processing 00000000.tx.167: 1999 suggested that calbindin controls the rate of insulin release via regulation of [Ca2+]i. 

Phrase: "1999"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that calbindin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0054444:Calbindin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the rate of insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "via regulation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.168: In addition, 1,25-dihydroxyvitamin D3 can enhance insulin secretion (Clark et al. 1981 ), indicating that both calbindin-D28K and vitamin D, together with calcium, may control -cell function. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "25-dihydroxyvitamin D3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]

Phrase: "can"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Clark et al. 1981"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "both calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "vitamin D,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C2936842:Vitamin D [Pharmacologic Substance]
  1000   C3537249:vitamin D [Pharmacologic Substance]
   861   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "together with calcium,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "may"

Phrase: "control -cell function."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   913   C2587213:Control function [Functional Concept]
   901   C0007613:Cell Function [Cell Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.169: However, Bourlon et al. 

Phrase: "However,"

Phrase: "Bourlon et al."
Processing 00000000.tx.170: 1996 showed that, in -cells, 1,25-dihydroxyvitamin D3 can stimulate insulin release but independently of calbindin-D28K. 

Phrase: "1996"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "in -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "25-dihydroxyvitamin D3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]

Phrase: "can"

Phrase: "stimulate"

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but independently of calbindin-D28K."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0054444:Calbindin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0233535:but [Mental or Behavioral Dysfunction]
Processing 00000000.tx.171: In contrast, these authors observed that in -cells vitamin D negatively regulates both calbindin-D28K expression and glucagon release, suggesting that the role of calbindin and vitamin D in Ca2+ handling is different in - and -cells. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "these authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that in -cells vitamin D negatively"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   840   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   840   C2936842:Vitamin D [Pharmacologic Substance]
   840   C3537249:vitamin D [Pharmacologic Substance]
   836   C0524984:cell d [Cell]
   804   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "regulates"

Phrase: "both calbindin-D28K expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "glucagon release,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the role of calbindin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "vitamin D in Ca2+ handling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   806   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   806   C2936842:Vitamin D [Pharmacologic Substance]
   806   C3537249:vitamin D [Pharmacologic Substance]
   760   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "is"

Phrase: "different in -"

Phrase: "and -"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.172: In agreement with the study of Bourlon et al. 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of Bourlon et al."
Processing 00000000.tx.173: 1996 , we observed calbindin-D28K immunostaining in both - and -cells, the clearest staining being present in the -cells. 

Phrase: "1996 ,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "calbindin-D28K immunostaining in both -"

Phrase: "and -"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "the clearest staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "being"

Phrase: "present in the -cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
Processing 00000000.tx.174: Thus far, ECaC1 has always been found to co-localize with calbindin-D (Hoenderop et al. 2000a ; Muller et al. 2000 ). 

Phrase: "Thus far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205108:far [Spatial Concept]

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "has"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "been"

Phrase: "found to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0150312:Found [Quantitative Concept]
   799 E C0243095:Find [Finding]

Phrase: "co-localize with calbindin-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0054444:Calbindin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392752:localize [Spatial Concept]

Phrase: "D ("

Phrase: "Hoenderop et al. 2000a"

Phrase: "; Muller et al. 2000"

Phrase: ")."
Processing 00000000.tx.175: Our observation that ECaC1 and calbindin-D28K co-localization is exclusively found in the -cells but not in the -cells suggests that the modulation of [Ca2+]i, in which both ECaC1 and calbindin-D28K may play a role, is different in - and -cells. 

Phrase: "Our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "calbindin-D28K co-localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]

Phrase: "is"

Phrase: "exclusively"

Phrase: "found in the -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0150312:Found [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not in the -cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1518422:Not [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the modulation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in which"

Phrase: "both ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "and"

Phrase: "calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "is"

Phrase: "different in -"

Phrase: "and -"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.176: This is in line with the notion of Bourlon et al. 

Phrase: "This"

Phrase: "is in line with the notion of Bourlon et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0205132:Line [Spatial Concept]
   739   C1550648:Line [Substance]
   739   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.177: 1996 . In ZDF rats, progression of diabetes is accompanied by a reduced expression of insulin (Pick et al. 1998 ). 

Phrase: "1996 ."

Phrase: "In ZDF rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "progression of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "is"

Phrase: "accompanied by a reduced expression of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(Pick et al. 1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1707391:Pick [Activity]
   812   C1826583:PICK [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.178: We now find that the expression of ECaC1 also is decreased in ZDF rats. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that"

Phrase: "the expression of ECaC1 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "decreased in ZDF rats."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   783   C0034719:Rats, Zucker [Mammal]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0241863:DIABETIC [Finding]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C2700303:Zucker [Mammal]
   719 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.179: The decrease in both insulin and ECaC1 was found at about 12 weeks of age and proceeded in a progressive way, at least until the age of 24 weeks. 

Phrase: "The decrease in both insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "was"

Phrase: "found at about 12 weeks of age"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0001779:Age [Organism Attribute]
   748   C0150312:Found [Quantitative Concept]
   748   C0439230:weeks [Temporal Concept]
   714 E C0243095:Find [Finding]
   714 E C0332174:/week [Temporal Concept]

Phrase: "and"

Phrase: "proceeded in a progressive way,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205329:Progressive [Functional Concept]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "until the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 24 weeks."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.180: In age-matched control rats, the decrease in insulin and ECaC1 expression was not observed, which suggests that this reduction is due to diabetes-related factors. 

Phrase: "In age-matched control rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "the decrease in insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "ECaC1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is due to diabetes-related factors."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C3146286:Due [Idea or Concept]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.181: One of the major characteristics of Type 2 DM is the impairment of glucose-induced insulin secretion. 

Phrase: "One of the major characteristics of Type 2 DM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the impairment of glucose-induced insulin secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.182: However, the underlying mechanism leading to this impairment is not known but may be based on either defective steps proximal to the elevation of [Ca2+]i or the exocytotic process distal to the increase in [Ca2+]i (Okamoto et al. 1995 ). 

Phrase: "However,"

Phrase: "the underlying mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "leading to this impairment"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0332152:Leading [Temporal Concept]
   770   C0684336:Impairment [Pathologic Function]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "be"

Phrase: "based on either defective steps"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   760   C0332452:Defective [Functional Concept]
   760   C1261552:steps [Conceptual Entity]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1704379:Step [Functional Concept]
   726 E C1705117:Step [Quantitative Concept]
   726 E C1880279:Base [Biomedical or Dental Material]
   726 E C2825408:Step [Manufactured Object]

Phrase: "proximal to the elevation of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205107:Proximal [Spatial Concept]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "the exocytotic process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "distal to the increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205108:Distal [Spatial Concept]

Phrase: "]i (Okamoto et al. 1995"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.183: As mentioned above, we propose a role for ECaC1 in cellular Ca2+ handling. 

Phrase: "As"

Phrase: "mentioned above,"

Phrase: "we"

Phrase: "propose"

Phrase: "a role for ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in cellular Ca2+ handling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018578:Handling [Behavior]
   827   C1832073:Handling [Finding]
Processing 00000000.tx.184: The decrease in ECaC1 expression in 24-week-old ZDF rats detected in the present study might lead to an insufficient increase of [Ca2+]i which, in turn, may impair insulin secretion. 

Phrase: "The decrease in ECaC1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in 24-week-old ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   845   C0034719:Rats, Zucker [Mammal]
   795   C0034693:rats [Mammal]
   795   C0034721:Rats [Mammal]

Phrase: "detected in the present study"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0150312:Present [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C2603343:Study [Research Activity]

Phrase: "might"

Phrase: "lead to an insufficient increase of [Ca2+"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0205412:Insufficient [Qualitative Concept]
   748   C0231180:Insufficient [Qualitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which,"

Phrase: "in turn,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0541749:turn [Finding]
   861   C1709743:Turn [Spatial Concept]

Phrase: "may"

Phrase: "impair"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.185: However, not only was ECaC1 expression decreased during development of diabetes but also insulin expression, indicating that the expression levels of several proteins of the -cell are affected. 

Phrase: "However,"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "was"

Phrase: "ECaC1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "decreased during development of diabetes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0205216:Decreased [Quantitative Concept]
   760   C0243107:development [Physiologic Function]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "but"

Phrase: "also insulin expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "indicating"

Phrase: "that"

Phrase: "the expression levels of several proteins of the -cell"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   745   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0441889:Levels [Qualitative Concept]
   731   C3244092:expression level [Idea or Concept]
   728   C0428479:Protein level [Laboratory or Test Result]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.186: Although multiple alterations in various protein levels in the -cell have been shown to contribute to the dysfunction of this cell type, the primary defect is still not known. 

Phrase: "Although"

Phrase: "multiple alterations in various protein levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "in the -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the dysfunction of this cell type,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   789   C0449475:Type of cell [Intellectual Product]
           cell type
   770   C0007634:Cell Type [Cell]
           Cell
   744   C0031847:dysfunction [Functional Concept]
   744   C0277785:Dysfunction, NOS [Qualitative Concept]
   744   C0332307:Type [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1547052:*Type [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1880177:Contribute [Activity]
   744   C1948049:Cell [Spatial Concept]

Phrase: "the primary defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1457869:Defect [Functional Concept]
   861   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is"

Phrase: "still"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.187: Male homozygous ZDF rats become hyperglycemic at about the age of 7 weeks and thereafter develop overt diabetes (Clark et al. 1983 ). 

Phrase: "Male homozygous ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C0034719:Rats, Zucker [Mammal]
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "become"

Phrase: "hyperglycemic at about"

Phrase: "the age of 7 weeks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "thereafter"

Phrase: "develop"

Phrase: "overt diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Clark et al. 1983"

Phrase: ")."
Processing 00000000.tx.188: Because no differences were detected in ECaC1 expression between 6-week-old control and ZDF rats and because the decrease occurs from 12 weeks of age onwards, this reduction in ECaC1 expression is probably not the primary event leading to -cell dysfunction in diabetes. 

Phrase: "Because"

Phrase: "no differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "detected in ECaC1 expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0221908:Epithelial [Qualitative Concept]
   753   C0439799:Channel [Spatial Concept]
   753   C0442726:Detected [Finding]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1706095:Channel [Conceptual Entity]

Phrase: "between 6-week-old control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "and"

Phrase: "because"

Phrase: "the decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "occurs from 12 weeks of age onwards,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0001779:Age [Organism Attribute]
   748   C0439230:weeks [Temporal Concept]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   714 E C0332174:/week [Temporal Concept]

Phrase: "this reduction in ECaC1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the primary event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to -cell dysfunction in diabetes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.189: As already mentioned, vitamin D together with calcium may modulate -cell function. 

Phrase: "As"

Phrase: "already"

Phrase: "mentioned"

Phrase: ","

Phrase: "vitamin D together with calcium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   844   C0719107:CALCIUM/VITAMIN D [Organic Chemical,Pharmacologic Substance,Vitamin]
   806   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   806   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   806   C2936842:Vitamin D [Pharmacologic Substance]
   806   C3537249:vitamin D [Pharmacologic Substance]
   760   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "may"

Phrase: "modulate -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "cell function."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.190: Our data show that aging of both control and ZDF rats is accompanied by a decrease in plasma 1,25-dihydroxyvitamin D3 levels, which confirms previous observations (Johnson et al. 1995 ). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that aging of both control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0001811:Ageing [Organism Function]

Phrase: "and"

Phrase: "ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "is"

Phrase: "accompanied by a decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]

Phrase: "in plasma 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "25-dihydroxyvitamin D3 levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "previous observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "(Johnson et al. 1995"

Phrase: ")."
Processing 00000000.tx.191: The reduction was similar in control and ZDF rats, indicating that the decrease of ECaC1 expression in the ZDF rats was not caused by the decrease of plasma 1,25-dihydroxyvitamin D3 concentrations and that, in the ZDF rats, the impaired -cell function is not due to changes in vitamin D3 concentrations. 

Phrase: "The reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "similar in control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "ZDF rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "indicating"

Phrase: "that"

Phrase: "the decrease of ECaC1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in the ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "caused by the decrease of plasma 1,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0032105:Plasma [Body Substance]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "25-dihydroxyvitamin D3 concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "that,"

Phrase: "in the ZDF rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "the impaired -cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0007613:Cell Function [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "not due to changes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1518422:Not [Functional Concept]
   770   C3146286:Due [Idea or Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in vitamin D3 concentrations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0008318:Vitamin D 3 [Pharmacologic Substance,Steroid,Vitamin]
   734   C3265062:vitamin D3 [Pharmacologic Substance]
Processing 00000000.tx.192: In conclusion, ECaC1 is abundantly expressed in rat pancreatic islets. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "is"

Phrase: "abundantly"

Phrase: "expressed in rat pancreatic islets."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
Processing 00000000.tx.193: Punctate cytoplasmic ECaC1 expression was restricted to the -cells, suggesting a localization of ECaC1 to the membranes of secretory granules. 

Phrase: "Punctate cytoplasmic ECaC1 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "restricted to the -cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0443288:Restricted [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a localization of ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "to the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "of secretory granules."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]
Processing 00000000.tx.194: We propose a function of ECaC1 in the maintenance of intracellular Ca2+ homeostasis either as part of a Ca2+ efflux pathway from granules to the cytoplasm or as a component of a Ca2+ influx pathway for extracellular Ca2+ into the cytoplasm. 

Phrase: "We"

Phrase: "propose"

Phrase: "a function of ECaC1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "in the maintenance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintenance [Activity]

Phrase: "of intracellular Ca2+ homeostasis either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0019868:Homeostasis [Biologic Function]

Phrase: "as part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of a Ca2+ efflux pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "from granules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0010837:Granules [Cell Component]
  1000   C0993609:Granules [Biomedical or Dental Material]
   916 E C0205248:Granular [Qualitative Concept]

Phrase: "to the cytoplasm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "or as a component of a Ca2+ influx pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0449432:Component [Manufactured Object]
   742   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C1704259:Pathway [Molecular Function]
   742   C1705248:Component [Conceptual Entity]
   742   C1705987:Pathway [Conceptual Entity]

Phrase: "for extracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "into the cytoplasm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]
Processing 00000000.tx.195: Furthermore, in ZDF rats a diabetes-related reduction of ECaC1 expression, independent of plasma 1,25-dihydroxyvitamin D3 levels, was demonstrated. 

Phrase: "Furthermore,"

Phrase: "in ZDF rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Rats, Zucker [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "a diabetes-related reduction of ECaC1 expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "independent of plasma 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "25-dihydroxyvitamin D3 levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "demonstrated."
Processing 00000000.tx.196: This decrease in ECaC1 expression in the ZDF rat may contribute to the impaired stimulussecretion coupling observed in diabetes. 

Phrase: "This decrease in ECaC1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in the ZDF rat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Zucker rat [Mammal]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]

Phrase: "may"

Phrase: "contribute to the impaired stimulussecretion coupling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0221099:Impaired [Functional Concept]
   753   C0684336:Impaired [Pathologic Function]
   753   C1880177:Contribute [Activity]
   753   C1948027:Coupling [Functional Concept]

Phrase: "observed in diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.197: Altogether, the present study suggests that ECaC1 may play an important role in the regulation of Ca2+ homeostasis in pancreatic -cells. 

Phrase: "Altogether,"

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ECaC1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the regulation of Ca2+ homeostasis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.198: Acknowledgments Supported by grant #95.116 from the Dutch Diabetes Foundation (Diabetes Fonds Nederland). 

Phrase: "Acknowledgments"

Phrase: "Supported by grant #95.116"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0018173:Grant [Quantitative Concept]
   760   C1521721:Supported [Conceptual Entity]
   760   C1548284:Grant [Idea or Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "from the Dutch Diabetes Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "(Diabetes Fonds Nederland"

Phrase: ")."
Processing 00000000.tx.199: JGJ Hoenderop was supported by a long-term EMBO fellowship (ALTF 160-2000). 

Phrase: "JGJ Hoenderop"

Phrase: "was"

Phrase: "supported by a long-term EMBO fellowship"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   778   C0443252:Long-term [Temporal Concept]
   748   C0015770:Fellowship [Educational Activity]
   748   C0205166:Long [Qualitative Concept]
   748   C1515273:Term [Temporal Concept]
   748   C1521721:Supported [Conceptual Entity]
   748   C1705313:Term [Idea or Concept]
   748   C1706317:Long [Qualitative Concept]
   748   C2826302:TERM [Intellectual Product]
   714 E C0183683:Support [Medical Device]

Phrase: "(ALTF 160-2000"

Phrase: ")."
Processing 00000000.tx.200: This work was also supported by the Dutch Organization of Scientific Research (Zon-Mw 016.006.001). 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "also"

Phrase: "supported by the Dutch Organization of Scientific Research"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   778   C1568415:Support of Research [Intellectual Product]
   770   C0683933:scientific research [Research Activity]
   767   C0035176:research supported [Quantitative Concept]
   767   C0683939:Research Organization [Manufactured Object,Organization]
   767   C0920650:scientific organization [Health Care Related Organization]
   744   C0013331:Dutch [Population Group]
   744   C0029237:Organisation [Physiologic Function]
   744   C0029246:Organization [Organization]
   744   C0035168:research [Research Activity]
   744   C0036397:Scientific [Occupation or Discipline]
   744   C0220885:organization [Qualitative Concept]
   744   C0242481:Research [Research Activity]
   744   C1300196:Organization [Functional Concept]
   744   C1521721:Supported [Conceptual Entity]
   744   C1522486:Organization [Professional or Occupational Group]
   711 E C0183683:Support [Medical Device]

Phrase: "(Zon-Mw 016.006.001"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0024548:MW [Geographic Area]
   804   C0026385:mw [Quantitative Concept]
   804   C0556966:mW [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.201: We are grateful to Dr S. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr S."
Processing 00000000.tx.202: Christakos (New Jersey) and Dr W.J.M van de Ven (Leuven, Belgium) for kindly providing antisera against calbindin-D28K and PC1, respectively. 

Phrase: "Christakos"

Phrase: "(New Jersey"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027971:New Jersey [Geographic Area]
   861   C0205314:New [Temporal Concept]
   861   C0454673:Jersey [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "Dr W.J.M van de Ven"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0011198:DE [Geographic Area]
   795   C0017480:DE [Geographic Area]
   795   C0042469:VEN [Geographic Area]
   795   C0557775:Van [Manufactured Object]
   795   C3541240:DE [Idea or Concept]

Phrase: "(Leuven,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: "for kindly providing antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "against calbindin-D28K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PC1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
   901   C1258132:Prohormone Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0301817:Prohormone [Hormone]

Phrase: "respectively."
Processing 00000000.tx.203: We also thank Annet Verleg and Henk Arnts (Central Animal Laboratory; University of Nijmegen, The Netherlands) for biotechnical assistance, Rob van den Berg (Department of Chemical Endocrinology; University Medical Centre Nijmegen, The Netherlands) for plasma 1,25-dihydroxyvitamin D3 measurements, and Anita Hartog (Department of Cell Physiology; University of Nijmegen, The Netherlands) for assistance in performing the immunofluorescence techniques. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Annet Verleg"

Phrase: "and"

Phrase: "Henk Arnts"

Phrase: "(Central Animal Laboratory"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1880016:Central Laboratory [Organization]
   901   C0003064:animal laboratory [Animal]
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C3244292:laboratory [Functional Concept]

Phrase: "; University of Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: "for biotechnical assistance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018896:Assistance [Social Behavior]

Phrase: "Rob van den Berg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0178587:DEN [Quantitative Concept]
   812   C0557775:Van [Manufactured Object]

Phrase: "(Department of Chemical Endocrinology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587463:Endocrinology department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "; University Medical Centre Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: "for plasma 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "25-dihydroxyvitamin D3 measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242485:measurements [Functional Concept]

Phrase: "and"

Phrase: "Anita Hartog"

Phrase: "(Department of Cell Physiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "; University of Nijmegen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: "for assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018896:Assistance [Social Behavior]

Phrase: "in performing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0884358:Perform [Functional Concept]
   966   C2947996:Perform [Pharmacologic Substance]

Phrase: "the immunofluorescence techniques."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0016318:Techniques, Immunofluorescence [Laboratory Procedure]
           Immunofluorescence
   972 E C0282649:Immunofluorescence Techniques, Direct [Laboratory Procedure]
   861   C0025664:techniques [Intellectual Product]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0449851:Techniques [Functional Concept]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.204: Received for publication October 29, 2001; 

Phrase: "Received for publication October 29,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2001"

Phrase: ";"
Processing 00000000.tx.205: accepted December 27, 2001. 

Phrase: "accepted December 27,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001."
Processing 00000000.tx.206: Literature Cited Top Summary Introduction Materials and Methods Results Discussion Literature Cited mml C, Larsson O, Berggren PO, Bokvist K, JunttiBerggren L, Kindmark H, Rosrsman P (1991) Inositol trisphosphate-dependent periodic activation of a Ca2+-activated K+ conductance in glucose-stimulated pancreatic beta-cells. 

Phrase: "Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "mml C,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Larsson O,"

Phrase: "Berggren PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Bokvist K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "JunttiBerggren L,"

Phrase: "Kindmark H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rosrsman P (1991"

Phrase: ")"

Phrase: "Inositol trisphosphate-dependent periodic activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "of a Ca2+-activated K+ conductance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1159689:K+ conductance [Cell Function]

Phrase: "in glucose-stimulated pancreatic beta-cells."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   884   C0030281:Pancreatic beta Cells [Cell]
           Beta cell
   804   C0007634:Cells [Cell]
   804   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   804   C0330390:Beta [Plant]
   804   C0439096:Beta [Intellectual Product]
   804   C2004068:Beta [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.207: Nature 353:849-852[Medline] Bailyes EMA, Shennan KIJ, Seal AJ, Smeekens SP, Steiner DF, Hutton JC, Docherty K (1992) A member of the eukaryotic subtilisin family (PC3) has the enzymic properties of the type 1 proinsulin-converting endopeptidase. 

Phrase: "Nature 353"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "849-852"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bailyes EMA,"

Phrase: "Shennan KIJ,"

Phrase: "Seal AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Smeekens SP,"

Phrase: "Steiner DF,"

Phrase: "Hutton JC,"

Phrase: "Docherty K (1992"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "A member of the eukaryotic subtilisin family"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "(PC3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2677316:PC-3 [Gene or Genome]

Phrase: ")"

Phrase: "has"

Phrase: "the enzymic properties of the type 1 proinsulin-converting endopeptidase."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   739   C0871161:properties [Qualitative Concept]
   739   C1292721:properties [Functional Concept]
   706 E C1882134:Property [Conceptual Entity]
   706 E C2347695:Property [Entity]
Processing 00000000.tx.208: Biochem J 285:391-394[Medline] Bindels RJM (1993) Calcium handling by the mammalian kidney. 

Phrase: "Biochem J 285"

Phrase: ":"

Phrase: "391-394"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bindels RJM"

Phrase: "(1993"

Phrase: ")"

Phrase: "Calcium handling by the mammalian kidney."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0018578:Handling [Behavior]
   753   C1832073:Handling [Finding]
Processing 00000000.tx.209: J Exp Biol 184:89-104[Abstract/Free FullText] Bokvist K, Eliasson L, mml C, Renstrom E, Rorsman P (1995) Co-localization of L-type Ca2+ channels and insulin-containing secretory granules and its significance for the initiation of exocytosis in mouse pancreatic B-cells. 

Phrase: "J Exp Biol 184"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "89-104"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bokvist K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Eliasson L,"

Phrase: "mml C,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Renstrom E,"

Phrase: "Rorsman P (1995"

Phrase: ")"

Phrase: "Co-localization of L-type Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "insulin-"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "secretory granules"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886515:Secretory Granules [Cell Component]
   966 E C3271154:Secretory Granule [Cell Component]
   861   C0010837:Granules [Cell Component]
   861   C0993609:Granules [Biomedical or Dental Material]
   861   C1327616:Secretory [Cell Function]
   777 E C0205248:Granular [Qualitative Concept]

Phrase: "and"

Phrase: "its significance for the initiation of exocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237881:Significance [Quantitative Concept]
   748   C0750502:Significance [Idea or Concept]

Phrase: "in mouse pancreatic B-cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   923   C0030281:Pancreatic B Cells [Cell]
   906   C1522109:Mouse B Cell [Cell]
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.210: EMBO J 14:50-57[Abstract] Bourlon PM, FaureDussert A, Billaudel B, Sutter BCJ, Tramu G, Thomasset M (1996) Relationship between calbindin-D28K levels in the A and B cells of the rat endocrine pancreas and the secretion of insulin and glucagon: influence of vitamin D3 deficiency and 1,25-dihydroxyvitamin D3. 

Phrase: "EMBO J 14"

Phrase: ":"

Phrase: "50-57"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bourlon PM, FaureDussert A,"

Phrase: "Billaudel B,"

Phrase: "Sutter BCJ,"

Phrase: "Tramu G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Thomasset"

Phrase: "M ("

Phrase: "1996"

Phrase: ")"

Phrase: "Relationship between calbindin-D28K levels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "in the A"

Phrase: "and"

Phrase: "B cells of the rat endocrine pancreas"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   788   C1522529:Endocrine pancreas cell [Cell]
   778   C0004561:B-Cells [Cell]
   774   C0229525:Endocrine Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the secretion of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1256369:insulin secretion [Cell Function]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ":"

Phrase: "influence of vitamin D3 deficiency"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   733   C1272352:Deficiency of vitamin D3 [Disease or Syndrome]

Phrase: "and"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "25-dihydroxyvitamin D3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]
Processing 00000000.tx.211: J Endocrinol 148:223-232[Abstract] Clark JB, Palmer CJ, Shaw WN (1983) The diabetic Zucker fatty rat. 

Phrase: "J Endocrinol 148"

Phrase: ":"

Phrase: "223-232"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Clark JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Palmer CJ,"

Phrase: "Shaw WN (1983"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1520114:WN [Mammal]

Phrase: ")"

Phrase: "The diabetic Zucker fatty rat."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0034719:Zucker rat [Mammal]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C2700303:Zucker [Mammal]
Processing 00000000.tx.212: Proc Soc Exp Biol Med 173:68-75[Abstract] Clark SA, Stumpf WE, Sar M (1981) Effect of 1,25 dihydroxyvitamin D3 on insulin secretion. 

Phrase: "Proc Soc Exp Biol Med 173"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1417055:EXP [Gene or Genome]
   799   C1418943:PROC [Gene or Genome]

Phrase: ":"

Phrase: "68-75"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450387:68 [Intellectual Product]

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Clark SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Stumpf"

Phrase: "WE,"

Phrase: "Sar"

Phrase: "M ("

Phrase: "1981"

Phrase: ")"

Phrase: "Effect of 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "25 dihydroxyvitamin D3 on insulin secretion."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]
Processing 00000000.tx.213: Diabetes 30:382-386[Abstract] Clark SA, Stumpf WE, Sar M, DeLuca HF, Tanaka Y (1980) Target cells for 1,25 dihydroxyvitamin D3 in the pancreas. 

Phrase: "Diabetes 30"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "382-386"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Clark SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Stumpf"

Phrase: "WE,"

Phrase: "Sar M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "DeLuca HF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018488:Hf [Element, Ion, or Isotope]
   861   C1538440:HF [Gene or Genome]
   861   C3273279:HF [Gene or Genome]

Phrase: "Tanaka Y (1980"

Phrase: ")"

Phrase: "Target cells for 1,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0221284:Target cells [Cell]
   833   C3272919:Target Cells [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "25 dihydroxyvitamin D3 in the pancreas."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]
Processing 00000000.tx.214: Cell Tissue Res 209:515-520[Medline] Davidson HW, Rhodes CJ, Hutton JC (1988) Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic -cell via two distinct site-specific endopeptidases. 

Phrase: "Cell Tissue Res 209"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007634:Cell [Cell]
   812   C0040300:Tissue [Tissue]
   812   C1269647:Cell [Cell]
   812   C1547928:Tissue [Intellectual Product]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "515-520"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Davidson HW,"

Phrase: "Rhodes CJ,"

Phrase: "Hutton JC"

Phrase: "(1988"

Phrase: ")"

Phrase: "Intraorganellar calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "and"

Phrase: "pH control proinsulin cleavage in the pancreatic -cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "via two distinct site-specific endopeptidases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030946:Endopeptidases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.215: Nature 333:93-96[Medline] Drucker DJ, Asa SL, Henderson J, Goltzman D (1989) The parathyroid hormone-like peptide (PLP) gene is expressed in the normal and neoplastic human endocrine pancreas. 

Phrase: "Nature 333"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "93-96"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Drucker DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Asa SL,"

Phrase: "Henderson J,"

Phrase: "Goltzman"

Phrase: "D ("

Phrase: "1989"

Phrase: ")"

Phrase: "The parathyroid hormone-like peptide"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0030520:Parathyroid Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1882913:PARATHYROID HORMONE [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C3536885:Parathyroid Hormone [Pharmacologic Substance]
   812   C0019932:Hormone [Hormone]
   812   C0030518:Parathyroid, NOS [Body Part, Organ, or Organ Component]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   741 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(PLP) gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "expressed in the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "neoplastic human endocrine pancreas."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0022131:Pancreas, Endocrine [Body Part, Organ, or Organ Component]
   861   C1283884:Endocrine pancreas [Body Part, Organ, or Organ Component]
   812   C0014136:Endocrine [Body System]
   812   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   812   C0521425:Endocrine [Functional Concept]
   812   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.216: Mol Endocrinol 3:1589-1595[Abstract] Eylen van F, Svoboda M, Herchuelz A (1997) Identification, expression pattern and potential activity of Na/Ca exchanger isoforms in rat pancreatic B-cells. 

Phrase: "Mol Endocrinol 3"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "1589-1595"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Eylen van F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Svoboda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Herchuelz A (1997"

Phrase: ")"

Phrase: "Identification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "expression pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Pattern [Spatial Concept]

Phrase: "and"

Phrase: "potential activity of Na/Ca exchanger isoforms"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "in rat pancreatic B-cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C0030281:Pancreatic B Cells [Cell]
   861   C0004561:B-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.217: Cell Calcium 21:185-193[Medline] Friedman PA, Gesek FA (1995) Cellular calcium transport in renal epithelia: measurement, mechanisms, and regulation. 

Phrase: "Cell Calcium 21"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: ":"

Phrase: "185-193"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Friedman PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Gesek FA (1995"

Phrase: ")"

Phrase: "Cellular calcium transport in renal epithelia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1159655:calcium transport [Cell Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: ":"

Phrase: "measurement,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:Measurement [Functional Concept]

Phrase: "mechanisms,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "regulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.218: Physiol Rev 75:429-471[Abstract/Free FullText] Gilon P, Shepherd RM, Henquin JC (1993) Oscillations of secretion driven by oscillations of cytoplasmic Ca2+ as evidences in single pancreatic islets. 

Phrase: "Physiol Rev 75"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "429-471"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gilon P,"

Phrase: "Shepherd RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Henquin JC"

Phrase: "(1993"

Phrase: ")"

Phrase: "Oscillations of secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "driven by oscillations of cytoplasmic Ca2+"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0010834:Cytoplasmic [Cell Component]
   753   C0521449:Cytoplasmic [Body Location or Region]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0695434:oscillations [Therapeutic or Preventive Procedure]
   719   C0013126:Drive [Mental Process]

Phrase: "as evidences"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "in single pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.219: J Biol Chem 268:22265-22268[Abstract/Free FullText] Hoenderop JGJ, Hartog A, Stuiver M, Doucet A, Willems PHGM, Bindels RJM (2000c) Localization of the epithelial Ca2+ channel in rabbit kidney and intestine. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "22265-22268"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoenderop JGJ,"

Phrase: "Hartog A,"

Phrase: "Stuiver M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Doucet A,"

Phrase: "Willems PHGM,"

Phrase: "Bindels RJM"

Phrase: "(2000c"

Phrase: ")"

Phrase: "Localization of the epithelial Ca2+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "in rabbit kidney"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0022646:Kidney [Body Part, Organ, or Organ Component]
   861   C0227665:kidney [Body Part, Organ, or Organ Component]
   861   C1278978:Kidney [Body Part, Organ, or Organ Component]
   861   C1514845:KIDNEY [Tissue]
   768 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "and"

Phrase: "intestine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021853:Intestine [Body Part, Organ, or Organ Component]
  1000   C1708548:INTESTINE [Tissue]
Processing 00000000.tx.220: J Am Soc Nephrol 11:1171-1178[Abstract/Free FullText] Hoenderop JGJ, Kemp van der AWCM, Hartog A, Os van CH, Willems PHGM, Bindels RJM (1999a) The epithelial calcium channel, ECaC, is activated by hyperpolarization and regulated by cytosolic calcium. 

Phrase: "J"

Phrase: "Am"

Phrase: "Soc Nephrol 11"

Phrase: ":"

Phrase: "1171-1178"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoenderop JGJ,"

Phrase: "Kemp van der AWCM,"

Phrase: "Hartog A,"

Phrase: "Os van CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0558269:Ch. [Professional or Occupational Group]
   827   C1552984:[Ch] [Quantitative Concept]

Phrase: "Willems PHGM,"

Phrase: "Bindels RJM"

Phrase: "(1999a"

Phrase: ")"

Phrase: "The epithelial calcium channel,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: "ECaC,"

Phrase: "is"

Phrase: "activated by hyperpolarization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "and"

Phrase: "regulated by cytosolic calcium."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1383501:Cytosolic [Cell Component]
   770   C2936886:Calcium [Pharmacologic Substance]
Processing 00000000.tx.221: Biochem Biophys Res Commun 261:488-492[Medline] Hoenderop JGJ, Kemp van der AWCM, Hartog A, van de Graaf SF, Willems PHGM, Bindels RJM (1999b) Molecular identification of the apical Ca2+ channel in 1,25-dihydroxyvitamin D3-responsive epithelia. 

Phrase: "Biochem Biophys Res Commun 261"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "488-492"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hoenderop JGJ,"

Phrase: "Kemp van der AWCM,"

Phrase: "Hartog A,"

Phrase: "van de Graaf SF,"

Phrase: "Willems PHGM,"

Phrase: "Bindels RJM"

Phrase: "(1999b"

Phrase: ")"

Phrase: "Molecular identification of the apical Ca2+ channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "in 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "25-dihydroxyvitamin D3-responsive epithelia."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   771   C0014609:Epithelium [Tissue]
   721 E C0221908:Epithelial [Qualitative Concept]
Processing 00000000.tx.222: J Biol Chem 274:8375-8378[Abstract/Free FullText] Hoenderop JGJ, Mller D, van der Kemp AWCM, Hartog A, Suzuki M, Ishibashi K, Imai M, Sweep F, Willems PHGM, Bindels RJM (2001) Calcitriol controls the epithelial calcium channnel in kidney. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "8375-8378"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoenderop JGJ,"

Phrase: "Mller D,"

Phrase: "van der Kemp AWCM,"

Phrase: "Hartog A,"

Phrase: "Suzuki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ishibashi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Imai M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sweep F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Willems PHGM,"

Phrase: "Bindels RJM"

Phrase: "(2001"

Phrase: ")"

Phrase: "Calcitriol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006674:Calcitriol [Hormone,Pharmacologic Substance,Steroid,Vitamin]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the epithelial calcium channnel in kidney."
Processing 00000000.tx.223: J Am Soc Nephrol 12:1342-1349[Abstract/Free FullText] Hoenderop JGJ, Mller D, Suzuki M, Os van CH, Bindels RJM (2000a) Epithelial calcium channel: gate-keeper of active calcium reabsorption. 

Phrase: "J"

Phrase: "Am"

Phrase: "Soc Nephrol 12"

Phrase: ":"

Phrase: "1342-1349"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoenderop JGJ,"

Phrase: "Mller D,"

Phrase: "Suzuki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Os van CH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0558269:Ch. [Professional or Occupational Group]
   827   C1552984:[Ch] [Quantitative Concept]

Phrase: "Bindels RJM"

Phrase: "(2000a"

Phrase: ")"

Phrase: "Epithelial calcium channel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0221908:Epithelial [Qualitative Concept]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   827   C2936886:Calcium [Pharmacologic Substance]

Phrase: ":"

Phrase: "gate-keeper of active calcium reabsorption."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0402606:Gate-keeper [Professional or Occupational Group]
   790   C1052868:gatekeeper [Eukaryote]
Processing 00000000.tx.224: Curr Opin Nephrol Hypertens 9:335-340[Medline] Hoenderop JGJ, Willems PHGM, Bindels RJM (2000b) Toward a comprehensive molecular model of active calcium reabsorption. 

Phrase: "Curr Opin Nephrol Hypertens 9"

Phrase: ":"

Phrase: "335-340"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hoenderop JGJ,"

Phrase: "Willems PHGM,"

Phrase: "Bindels RJM"

Phrase: "(2000b"

Phrase: ")"

Phrase: "Toward a comprehensive molecular model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0026344:Molecular Model [Intellectual Product]
   827   C3161035:Model [Intellectual Product]

Phrase: "of active calcium reabsorption."
Processing 00000000.tx.225: Am J Physiol 278:F352-360 Hoof van HJC, Swinkels LMJW, Stevenhagen van JJ, Berg van den H, Ross HA, Benraad TJ (1993) Advantages of paper chromatography as a preparative step in the assay of 1,25-dihydroxyvitamin D. 

Phrase: "Am"

Phrase: "J Physiol 278"

Phrase: ":"

Phrase: "F352-360 Hoof van HJC,"

Phrase: "Swinkels LMJW,"

Phrase: "Stevenhagen van JJ,"

Phrase: "Berg van den H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "Ross HA,"

Phrase: "Benraad TJ (1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039247:TJ [Geographic Area]

Phrase: ")"

Phrase: "Advantages of paper chromatography"

Phrase: "as a preparative step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "the assay of 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0243073:assay [Qualitative Concept]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "25-dihydroxyvitamin D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0012328:dihydroxyvitamin d [Pharmacologic Substance,Steroid,Vitamin]
Processing 00000000.tx.226: J Chromatogr 17:33-39 Ishida H, Seino Y, Seino S, Tsuda K, Takemura J, Nishi S, Ishizuka S, Imura H (1983) Effect of 1,25-dihydroxyvitamin D3 on pancreatic B and D cell function. 

Phrase: "J Chromatogr 17"

Phrase: ":"

Phrase: "33-39 Ishida H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "Seino Y,"

Phrase: "Seino S,"

Phrase: "Tsuda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Takemura J,"

Phrase: "Nishi S,"

Phrase: "Ishizuka S,"

Phrase: "Imura H (1983"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "Effect of 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "25-dihydroxyvitamin D3 on pancreatic B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]

Phrase: "and"

Phrase: "D cell function."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007613:Cell Function [Cell Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0524984:D Cell [Cell]
Processing 00000000.tx.227: Life Sci 33:1779-1786[Medline] Jackson RS, Creemers JW, Ohagi S, RaffinSanson ML, Sanders L, Montague CT, Hutton JC, O'Rahilly S (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. 

Phrase: "Life Sci 33"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0376558:Life [Idea or Concept]
   827   C3642273:SCI [Professional or Occupational Group]
   743 E C0595998:lives [Finding]

Phrase: ":"

Phrase: "1779-1786"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jackson RS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539879:RS [Idea or Concept]

Phrase: "Creemers JW,"

Phrase: "Ohagi S,"

Phrase: "RaffinSanson ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Sanders L,"

Phrase: "Montague CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449864:Threshold [Qualitative Concept]

Phrase: "Hutton JC,"

Phrase: "O'Rahilly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "S ("

Phrase: "1997"

Phrase: ")"

Phrase: "Obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "impaired prohormone processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709694:Processing [Activity]

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the human prohormone convertase 1 gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0314604:Human gene [Gene or Genome]
   804   C0017337:Gene [Gene or Genome]
   717   C0135615:Prohormone Convertase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1418388:PROHORMONE CONVERTASE 1 [Gene or Genome]
Processing 00000000.tx.228: Nature Genet 16:303-306[Medline] Johnson JA, Beckman MJ, PansiniPorta A, Christakos S, Bruns ME, Beitz DC, Horst RL, Reinhardt TA (1995) Age and gender effects on 1,25-dihydroxyvitamin D3-regulated gene expression. 

Phrase: "Nature Genet 16"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0325074:Genet [Mammal]
   827   C0349590:Nature [Idea or Concept]
   827   C1262865:Nature [Functional Concept]
   755 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "303-306"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson JA,"

Phrase: "Beckman MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "PansiniPorta A,"

Phrase: "Christakos S,"

Phrase: "Bruns"

Phrase: "ME,"

Phrase: "Beitz DC,"

Phrase: "Horst RL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]

Phrase: "Reinhardt TA (1995"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1506978:Ta [Immunologic Factor]
   827   C1705538:TA [Idea or Concept]

Phrase: ")"

Phrase: "Age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "gender effects on 1,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0079399:Gender [Organism Attribute]
   770   C0804628:Gender [Clinical Attribute]
   770   C1280500:effects [Qualitative Concept]
   770   C1522384:Gender [Organism Attribute]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "25-dihydroxyvitamin D3-regulated gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017262:Gene Expression [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.229: Exp Gerontol 30:631-643[Medline] Johnson JA, Grande JP, Roche PC, Kumar R (1994) Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin-D28K in human and rat pancreas. 

Phrase: "Exp Gerontol 30"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "631-643"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson JA,"

Phrase: "Grande JP,"

Phrase: "Roche PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Kumar R (1994"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Immunohistochemical localization of the 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "25"

Phrase: "(OH)2D3 receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "calbindin-D28K in human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "rat pancreas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.230: Am J Physiol 267:E356-360[Abstract/Free FullText] Lee S, Clark SA, Gill RK, Christakos S (1984) 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. 

Phrase: "Am"

Phrase: "J Physiol 267"

Phrase: ":"

Phrase: "E356-360"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee S,"

Phrase: "Clark SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Gill RK,"

Phrase: "Christakos"

Phrase: "S ("

Phrase: "1984"

Phrase: ")"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "25-Dihydroxyvitamin D3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0766510:dihydroxy-vitamin D3 [Organic Chemical,Vitamin]

Phrase: "and"

Phrase: "pancreatic beta-cell function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   902   C0232786:Pancreatic function [Organ or Tissue Function]
   861   C0007613:Cell Function [Cell Function]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   756   C0030281:Pancreatic beta cell [Cell]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: ":"

Phrase: "vitamin D receptors,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0108082:Vitamin D Receptors [Amino Acid, Peptide, or Protein,Receptor]
   966 E C0919430:VITAMIN D RECEPTOR [Gene or Genome]
   901   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C2936842:Vitamin D [Pharmacologic Substance]
   901   C3537249:vitamin D [Pharmacologic Substance]
   896   C0597673:vitamin receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "gene expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.231: Endocrinology 134:1602-1610[Abstract] Mller D, Hoenderop JGJ, Meij IC, van den Heuvel LP, Knoers NV, den Hollander AI, Eggert P, GarciaNieto V, ClaverieMartin F, Bindels RJM (2000) Molecular cloning, tissue distribution, and chromosomal mapping of the human epithelial Ca2+ channel (ECaC1). 

Phrase: "Endocrinology 134"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "1602-1610"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Mller D,"

Phrase: "Hoenderop JGJ,"

Phrase: "Meij IC,"

Phrase: "van den Heuvel LP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C0228341:LP [Body Part, Organ, or Organ Component]
   812   C2239920:LP [Gene or Genome]

Phrase: "Knoers NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027951:NV [Geographic Area]
   861   C3540591:NV [Idea or Concept]

Phrase: "den Hollander AI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003353:AI [Geographic Area]
   827   C0003504:ai [Disease or Syndrome]

Phrase: "Eggert P,"

Phrase: "GarciaNieto V,"

Phrase: "ClaverieMartin F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bindels RJM"

Phrase: "(2000"

Phrase: ")"

Phrase: "Molecular cloning,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "tissue distribution,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040287:Tissue Distribution [Quantitative Concept]
  1000   C0220927:tissue distribution [Functional Concept]
   861   C0040300:Tissue [Tissue]
   861   C0520511:distribution [Idea or Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "chromosomal mapping of the human epithelial Ca2+ channel (ECaC1)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1283195:Mapping [Activity]
   735   C0008630:Chromosome Mapping [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.232: Genomics 67:48-53[Medline] Norman AW, Frankel BJ, Heldt AM, Grodsky GM (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. 

Phrase: "Genomics 67"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "48-53"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Norman AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Frankel BJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005005:BJ [Geographic Area]

Phrase: "Heldt"

Phrase: "AM"

Phrase: ","

Phrase: "Grodsky GM (1980"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: ")"

Phrase: "Vitamin D deficiency"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0042870:Vitamin D Deficiency [Disease or Syndrome]
   913   C0376286:vitamin deficiency [Disease or Syndrome]
   913   C1510471:Vitamin Deficiency [Disease or Syndrome]
   901   C0014695:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C0042866:Vitamin D [Organic Chemical,Pharmacologic Substance,Vitamin]
   901   C2936842:Vitamin D [Pharmacologic Substance]
   901   C3537249:vitamin D [Pharmacologic Substance]
   827   C0011155:Deficiency [Functional Concept]
   827   C0042890:Vitamin [Organic Chemical,Pharmacologic Substance,Vitamin]
   827   C0162429:Deficiency [Disease or Syndrome]
   827   C1623416:deficiency [Qualitative Concept]
   755 E C1636779:% deficient [Quantitative Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "pancreatic secretion of insulin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0030296:Pancreatic Secretion [Body Substance]
   833   C0232787:Pancreatic secretion [Organ or Tissue Function]
   819   C1256369:insulin secretion [Cell Function]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
Processing 00000000.tx.233: Science 209:823-825[Medline] Okamoto Y, Ishida H, Taminato T, Tsuji K, Kurose T, Tsuura Y, Kato S, Imura H, Seino Y (1992) Role of cytosolic Ca2+ in impaired sensitivity to glucose of rat pancreatic islets exposed to high glucose in vitro. 

Phrase: "Science 209"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "823-825"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Okamoto Y,"

Phrase: "Ishida H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Taminato T,"

Phrase: "Tsuji K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kurose T,"

Phrase: "Tsuura Y,"

Phrase: "Kato S,"

Phrase: "Imura H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Seino Y (1992"

Phrase: ")"

Phrase: "Role of cytosolic Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in impaired sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "of rat pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "exposed to high glucose"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   833   C0860803:high glucose [Finding]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205250:High [Qualitative Concept]
   770   C1299351:High [Qualitative Concept]
   770   C2700149:HIGH [Intellectual Product]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.234: Diabetes 41:1555-1561[Abstract] Okamoto Y, Ishida H, Tsuura Y, Yasuka K, Kato S, Matsubara H, Nishimura M, Mizuno N, Ikeda H, Seino Y (1995) Hyperresponse in calcium-induced insulin release from electrically permeabilized pancreatic islets of diabetic GK rats and its defective augmentation by glucose. 

Phrase: "Diabetes 41"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "1555-1561"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Okamoto Y,"

Phrase: "Ishida H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Tsuura Y,"

Phrase: "Yasuka K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kato S,"

Phrase: "Matsubara H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nishimura M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mizuno N,"

Phrase: "Ikeda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Seino Y (1995"

Phrase: ")"

Phrase: "Hyperresponse in calcium-induced insulin release"

Phrase: "from electrically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013790:Electrically [Natural Phenomenon or Process]

Phrase: "permeabilized"

Phrase: "pancreatic islets of diabetic GK rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "its defective augmentation by glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1293122:Augmentation [Therapeutic or Preventive Procedure]
Processing 00000000.tx.235: Diabetologia 38:772-778[Medline] Pick A, Clark J, Kubstrup C, Levisetti M, Pugh W, BonnerWeir S, Polonsky KS (1998) Role of apoptosis in failure of -cell mass compensation for insulin resistance and -cell defects in the male Zucker diabetic fatty rat. 

Phrase: "Diabetologia 38"

Phrase: ":"

Phrase: "772-778"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pick A,"

Phrase: "Clark J,"

Phrase: "Kubstrup C,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "Levisetti M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Pugh W,"

Phrase: "BonnerWeir S,"

Phrase: "Polonsky KS (1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3541894:ks [Quantitative Concept]

Phrase: ")"

Phrase: "Role of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in failure of -cell mass compensation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0152057:Compensation [Mental Process]
   804   C0152058:Compensation [Physiologic Function]
   804   C0220808:Compensation [Quantitative Concept]

Phrase: "for insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and -"

Phrase: "cell defects in the male Zucker diabetic fatty rat."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0243067:defects [Functional Concept]
   708 E C1457869:Defect [Functional Concept]
   708 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.236: Diabetes 47:358-364[Abstract] Roe MW, Lancaster ME, Mertz RJ, Worley JF, III, Dukes ID (1993) Voltage-dependent intracellular calcium release from mouse islets stimulated by glucose. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "358-364"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Roe MW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024548:MW [Geographic Area]
   861   C0026385:mw [Quantitative Concept]
   861   C0556966:mW [Quantitative Concept]

Phrase: "Lancaster"

Phrase: "ME,"

Phrase: "Mertz RJ,"

Phrase: "Worley JF,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "Dukes ID (1993"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0600091:ID [Intellectual Product]
   827   C1512090:Dukes [Classification]
   793 E C1446468:Duke [Laboratory Procedure]

Phrase: ")"

Phrase: "Voltage-dependent intracellular calcium release from mouse islets"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "stimulated by glucose."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1948023:Stimulated [Natural Phenomenon or Process]
Processing 00000000.tx.237: J Biol Chem 268:9953-9956[Abstract/Free FullText] Sooy K, Schermerhorn T, Noda M, Surana M, Rhoten WB, Meyer M, Fleischer N, Sharp GW, Christakos S (1999) Calbindin-D28K controls [Ca2+]i and insulin release. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "9953-9956"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sooy K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Schermerhorn T,"

Phrase: "Noda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Surana M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rhoten WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582525:Wb [Quantitative Concept]

Phrase: "Meyer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fleischer N,"

Phrase: "Sharp GW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]

Phrase: "Christakos"

Phrase: "S ("

Phrase: "1999"

Phrase: ")"

Phrase: "Calbindin-D28K controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
   734   C0108048:Calbindin-D28K [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "insulin release."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.238: Evidence obtained from calbindin-D 28K(knockout mice and  cell lines. 

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "obtained from calbindin-D 28K"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0054444:Calbindin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(knockout mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206745:Knock-out Mice [Mammal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "cell lines."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.239: J Biol Chem 274):34343-34349 Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI (1995) Evolution of -cell dysfunction in the male Zucker diabetic fatty rat. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ")"

Phrase: ":"

Phrase: "34343-34349 Tokuyama Y,"

Phrase: "Sturis J,"

Phrase: "DePaoli"

Phrase: "AM"

Phrase: ","

Phrase: "Takeda J,"

Phrase: "Stoffel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tang J,"

Phrase: "Sun X,"

Phrase: "Polonsky KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Bell GI (1995"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706917:Bell [Manufactured Object]
   827   C3539617:GI [Idea or Concept]

Phrase: ")"

Phrase: "Evolution of -cell dysfunction in the male Zucker diabetic fatty rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0031847:dysfunction [Functional Concept]
   738   C0277785:Dysfunction, NOS [Qualitative Concept]
Processing 00000000.tx.240: Diabetes 44:1447-1457[Abstract] Vennekens R, Hoenderop JGJ, Prenen J, Stuiver M, Willems PHGM, Droogmans G, Nilius B, Bindels RJM (2000) Permeation and gating properties of the novel epithelial calcium channel. 

Phrase: "Diabetes 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "1447-1457"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Vennekens R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hoenderop JGJ,"

Phrase: "Prenen J,"

Phrase: "Stuiver M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Willems PHGM,"

Phrase: "Droogmans G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Nilius B,"

Phrase: "Bindels RJM"

Phrase: "(2000"

Phrase: ")"

Phrase: "Permeation"

Phrase: "and"

Phrase: "gating properties of the novel epithelial calcium channel."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0871161:properties [Qualitative Concept]
   744   C1292721:properties [Functional Concept]
   711 E C1882134:Property [Conceptual Entity]
   711 E C2347695:Property [Entity]
Processing 00000000.tx.241: J Biol Chem 275:3963-3969[Abstract/Free FullText] VillanuevaPeacarrillo ML, Cancelas J, Miguel de F, Redondo A, Valin A, Valverde I, Esbrit P (1999) Parathyroid hormone-related peptide stimulates DNA synthesis and insulin secretion in pancreatic islets. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3963-3969"

Phrase: "[Abstract/Free FullText"

Phrase: "] VillanuevaPeacarrillo ML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "Cancelas J,"

Phrase: "Miguel de F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Redondo A,"

Phrase: "Valin A,"

Phrase: "Valverde I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Esbrit P (1999"

Phrase: ")"

Phrase: "Parathyroid hormone-related peptide"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0070099:Parathyroid Hormone-Related Peptide [Amino Acid, Peptide, or Protein,Hormone]
   861   C0030520:Parathyroid Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1882913:PARATHYROID HORMONE [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C3536885:Parathyroid Hormone [Pharmacologic Substance]
   812   C0019932:Hormone [Hormone]
   812   C0030518:Parathyroid, NOS [Body Part, Organ, or Organ Component]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0458083:Hormonal [Qualitative Concept]
   741 E C0869014:Relations [Social Behavior]

Phrase: "stimulates"

Phrase: "DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "insulin secretion in pancreatic islets."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C1256369:insulin secretion [Cell Function]
   797   C0030296:Pancreatic Secretion [Body Substance]
   797   C0232787:Pancreatic secretion [Organ or Tissue Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.242: J Endocrinol 163:403-408[Abstract/Free FullText]

Phrase: "J Endocrinol 163"

Phrase: ":"

Phrase: "403-408"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

